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ABSTRACT
The i n h e r i t e d  a nae s t he t i c  compl icat ion Malignant  Hyperpyrexia (MH) i s
?+thought  to  be due to  an abnormal i ty of  ske l e t a l  muscle Ca
2+r e g u l a t i o n .  Because of t h i s  the Ca -dependent r egu la to ry  pro te in
2  +calmodul in was i n ve s t i g a t e d  as a p os s i b l e  cause of abnormal Ca
r e g u l a t i o n  in MH su sc ep t i b l e  (MHS) porcine muscle.  Calmodulin i s
2+known to  r egu l a t e  i n t r a c e l l u l  ar Ca concen t ra t i ons  and to modulate 
2+t he  e f f e c t s  of Ca in many t i s s u e s .
The calmodulin an t agon i s t  drugs were shown to a f f e c t  the  c o n t r a c t i l e  
c h a r a c t e r i s t i c s  of both cont rol  and MHS porcine s ke l e t a l  muscle in 
v i t r o . These drugs induced c on t r a c t u r e  in control  and MHS muscle.  
Calmodulin an t agon i s t s  a l so induced MH-like hypercont rac t i  1 i t y  in 
cont rol  muscle and p o te n t i a t ed  the h y p e r c o n t r a c t i l i t y  of MHS muscle.  
These e f f e c t s  were c on s i s t e n t  with the calmodulin an t agon i s t  drugs 
inducing an i nc rease  in myoplasmic Ca ' concent ra t ion  in both
cont ro l  and MHS muscle.  Dantrolene sodium was able to p a r t i a l l y  
r ever se  c on t r ac t u r e s  induced by calmodulin antagoni s t  drugs in both 
cont ro l  and MHS porc ine  muscle.
The p r o t e in  calmodulin was i s o l a t e d  from cont rol  and MHS porcine 
b ra in  by an a f f i n i t y  chromatography procedure.  Control and MHS 
calmodul ins behaved i d e n t i c a l l y  dur ing the i s o l a t i o n  procedure and 
were i n d i s t i n g u i s h a b l e  by gel e l e c t r op h or e s i s  or  by t h e i r  UV 
absorbance sp ec t r a .  The a b i l i t y  of cont rol  and MHS calmodulins to 
a c t i v a t e  phosphodies te rase  and to be i n h i b i t e d  by an t agoni s t  drugs 
were a lso i d e n t i c a l .  I t  was concluded t h a t  cont rol  and MHS
calmodul ins did not  d i f f e r .
The sarcoplasmic reticulum (SR) of control and MHS porcine skeletal
muscle was investigated as a possible s ite of action of the
calmodulin antagonist drugs. These drugs inhibited the
2+Ca -dependent ATPase ac tiv ity  of isolated SR preparations in a
dose-dependent manner. The extent of th is  inh ib ition  was the same in
both control and MHS SR. Calmodulin antagonist drugs inhibited the 
2+ATP-dependent Ca uptake a c tiv ity  of isolated SR preparations from
both control and MHS muscle to a sim ilar extent. Also, the efflux of 
2+Ca from isolated SR preparations was accelerated by calmodulin
antagonist drugs. The extent of th is  acceleration was the same in
both control and MHS SR. These effects of calmodulin antagonist 
2+drugs on SR Ca transport functions were consistent with the ir in
v itro  pharmacological effects on control and MHS skeletal muscle.
That is , these drugs affected the contractile characteristies of
2+control and MHS muscle by raising the myoplasmic Ca concentration.
Dantrolene sodium was unable to reverse the effects of the calmodulin
antagonist drugs on brain calmodulin a c tiv ity  or skeletal muscle SR 
2+Ca transport functions of either control or MHS tissue. However 
dantrolene sodium did p a rtia lly  reverse the contractures induced by 
calmodulin antagonist drugs j_n v it r o . Since dantrolene sodium is 
thought to act on the excitation-contraction coupling mechanism, 
these observations suggested that the calmodulin antagonist drugs 
were acting, in part, on th is mechanism to induce the changes in 
contractile  characteristics observed in both control and MHS muscle 
in v it ro .
Many of the calmodulin antagonist drugs used in the present
investigation are c lin ic a lly  useful antipsychotics. The in v itro
2+effects of these drugs, that is , the increasing of myoplasmic Ca
concentrations, may be involved in two in vivo side effects of
antipsychotic therapy. Firstly, patients undergoing antipsychotic 
therapy are at risk from heat stroke in high environmental 
temperatures. Secondly, psychiatric patients may experience a rare 
and dramatic side effect of antipsychotic therapy, the Neuroleptic 
Malignant Syndrome (NMS). The symptoms of NMS are similar to those 
of MH. Diagnostic studies in the present investigation and elsewhere 
have shown that NMS may be associated with MH.
The observations on the effects of calmodulin antagonist drugs on
control and MHS porcine skeletal muscle strengthen the hypothesis
2+that MH may be due to an abnormally high myoplasmic Ca
2+concentration. Calmodulin antagonist drugs raised myoplasmic Ca
2+concentrations by their effects on the SR Ca transport functions 
and excitation-contraction coupling, thereby inducing MH-like 
hypercontractility in control muscle in vitro. An analysis of the
effects of individual calmodulin antagonist drugs on control and MHS 
skeletal muscle implicated the excitation-contraction coupling 
mechanism as the site of the basic abnormality in porcine MH.
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CHAPTER 1 INTRODUCTION
1.1 The Malignant Hyperprexia Syndrome
Malignant Hyperpyrexia (MH) was first described in 1960 in a family 
in which 10 members had died during general anaesthesia (Denborough 
and Lovell, 1960). The propositus had exhibited a drastic reaction 
to anaesthesia given for the reduction of a compound fracture but had 
survived. Since that time MH has been recognized as an inherited 
complication of general anaesthesia. Susceptible individuals have a 
skeletal muscle abnormality which is associated with at least three 
clinically defined myopathies (King, Denborough and Zapf, 1972; 
Denborough, Dennett and Anderson, 1973; Moulds and Denborough,
1974d). Estimates of the incidence of MH put it at approximately 
1/14,000 general anaesthetics (McPherson and Taylor, 1982).
1.2 Clinical Features of Malignant Hyperpyrexia
The onset of a MH episode is often sudden, either during or a short 
time after anaesthesia (Denborough, 1980). The early signs may
include tachycardia, a falling blood pressure, arrhythmias,
tachypnoea, sweating and cyanosis of the skin (Nissen and Yonkers, 
1982). Muscle rigidity is present in 70-80% of cases. Later a rapid 
and sustained rise in body temperature is observed. Serum 
electrolyte estimations reveal a high potassium level and blood gas 
analysis shows high carbon dioxide output. Serum estimations show 
massive increases in muscle enzyme levels such as creatine 
phosphokinase (CPK), lactate dehydrogenase (LDH), glutamic oxalic 
transaminase (GOT) and hydroxybutyryl dehydrogenase (HBDH) (Britt, 
1979). Late complications include disseminated intravascular
2 .
coagulation, myoglobinuria and renal failure.  A mortality rate of 
60-70% is observed.
1.3 Anaesthetic Triggers of Malignant Hyperpyrexia
Most potent inhalational anaesthetics will induce MH in susceptible 
individuals. These include halothane, methoxyflurane, diethyl ether, 
ethylchloride, trichioroethylene, cyclopropane and ethylene. The 
muscle relaxants succinylcholine and gallamine are also triggering 
agents for MH.
Safe anaesthesia is possible in MH susceptible (MHS) patients by the 
use of local, regional or spinal anaesthesia, or thiopentone, nitrous 
oxide, d-tubocurarine, belladonna alkaloids and althesin (Denborough,
1980) .
1.4 Treatment of Malignant Hyperpyrexia
Fortunately, there is a drug available which has the ability to 
prevent or reverse a MH episode, the muscle relaxant dantrolene 
sodium (DANTRIUM, Norwich Pharmaceuticals) (Ellis and Bryant, 1972; 
Kolb, Horne and Martz, 1982). When an MH episode occurs during 
surgery, anaesthesia should be discontinued and the operation 
terminated. Dantrolene sodium should be given intravenously starting 
with an in i t ia l  dose of 1-1.5 mg/kg, and repeated up to a cumulative 
dose of 10 mg/kg as long as the symptoms of MH persist (Aldrete,
1981) .
Cooling, hyperventilation with oxygen and correction of acidosis and 
electrolyte abnormalities are also important early steps in the
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treatment of MH. Cooling can be accomplished by immersion in ice and 
water baths. Metabolic acidosis can be treated with sodium 
bicarbonate. Diuretics such as mannitol help prevent hypernatremia 
from large quanti t ies  of sodium bicarbonate. Cardiac arrhythmias can 
be controlled by correction of f lu id  and e lectro ly te  imbalances, 
however cardiac ac t iv i ty  should be monitored continuously. 
Hyperkalemia may be reversed using 50% dextrose with soluble insulin . 
Coagulation studies should also be performed; heparin can be used to 
control coagulation i f  i t  develops. Finally, i t  is  important to 
monitor patients  closely even a f te r  resolution of symptoms since 
fa ta l  recurrences of MH have been reported as occuring several hours 
l a t e r  (Nissen and Yonkers, 1982).
1.5 The Genetics of Malignant Hyperpyrexia
Three c l in ica l  myopathies predisposing to MH have been defined. The 
Evans myopathy is  the most common myopathy predisposing to MH, 
accounting for approximately 50% of MHS individuals (King, Denborough 
and Zapf, 1972; B r i t t ,  Endrenyi, Peters, Kwong and Kadijevic, 1976). 
I t  i s  usually sub-clinical although some muscle wasting may occur, 
and is  inherited as a Mendelian dominant charac ter is t ic  (Denborough, 
Ebeling, King and Zapf, 1970; McPherson and Taylor, 1982). Affected 
individuals may display elevated serum CPK levels (Isaacs and Barlow, 
1970).
The King-Denborough syndrome is  usually found in boys and is  probably 
inherited as a recessive charac te r is t ic  (King and Denborough, 1973). 
The boys are usually small for th e i r  age and have undescended tes te s ,
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thoracic kyphosis, lumbar lordosis ,  pectus carinatum, low-set ears 
and ptosis .
Central-core disease is  an uncommon myopathy and is often associated 
with MH (Denborough, Dennett and Anderson, 1973). This myopathy is
characterized by s t r ik ing  'core '  lesions in muscle f ibres  on
histological  examination.
Although MH episodes have been reported in patients suffering from 
congenital muscular dystrophy (Fletcher,  Blennow, Olsson, Ranklev and 
Tornebrant, 1982) and Duchenne's muscular dystrophy (Kelfer, Singer 
and Reynolds, 1983), pharmacological tes t ing of muscle from patients 
with these and other muscle diseases does not show the
hypercontracti1i ty  which is  charac te r i s t ic  of MH suscep t ib i l i ty  
(Moulds and Denborough, 1974d).
1.6 The Diagnosis of Malignant Hyperpyrexia
The most widely accepted and re l iab le  method of diagnosing
suscep t ib i l i ty  to MH is  the in v i t ro  muscle contracture t e s t  (Kalow, 
B r i t t ,  Terreau and Haist,  1970; E l l i s ,  Keaney, Harriman, Sumner, 
Kyei-Mensah, Tyrre l l ,  Hargreaves, Parikh and Mulrooney, 1972; Moulds 
and Denborough, 1974b). This procedure necessitates  the excision of 
a muscle biopsy specimen, usually from the vastus l a t e r a l i s .  Fibre 
bundles are cut from the specimen and suspended in a physiological 
solution, supplied with glucose and oxygen, and maintained at body 
temperature. The muscle s t r ip s  are then exposed to 3% halothane, 2mM 
caffeine, ImM succinylcholine (ANECTINE, Wellcome Australia Ltd.) and
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80mM potassium ch lo r ide . Muscle s tr ip s  from susceptible ind iv idua ls  
show increased contracture responses at these concentrations.
Other jn_ v i t r o  methods fo r  id e n t i fy in g  s u s c e p t ib i l i ty  to MH using 
muscle biopsy specimens have been proposed. The ATP depletion test 
was based on the observation of a decrease in the ATP concentration 
in  MH muscle exposed to halothane (Harrison, Saunders, Biebuyck, 
Hickman, Dent, Weaver and Torblanche, 1969). I t  was found, however, 
tha t th is  tes t did not id e n t i fy  a l l  of the MHS population ( B r i t t ,  
Endrenyi, Kalow and Peters, 1976). An increase in myophosphorylase A 
in  MH muscle has been proposed as a d iagnostica lly  useful tes t by 
W iliner, Wood, Cerri and B r i t t  (1980), but when th is  parameter was 
studied by another group (Traynor, Van Dyke and Gronert, 1983) an 
unacceptably high number of fa lse  pos it ive  responses were observed.
In the diagnosis of MH, muscle biopsy specimens are also taken fo r  
hi stopathological and electron microscopic examination. Not a l l  MHS 
patients show muscle pathology and the changes are not sp e c if ic .  In 
a reported series of 80 MH patients 35 showed myopathic changes at 
biopsy (Harriman, 1982). The most frequent myopathic change was 
in te rna l nuc le i, and others included fla ttened  f ib re s ,  small angular 
basophilic f ib re s ,  f ib r e  s p l i t t in g ,  moderate atrophy, moth-eaten and 
core-targeto id f ib re s .
The disadvantage of the above diagnostic methods is  th e ir  invasive 
nature. A number of studies have been reported in which blood ce lls  
or serum enzymes have been investigated fo r  th e ir  diagnostic value in 
MH. P la te le t aggregation was shown to be normal in MHS ind iv idua ls
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(Rosenberg, Fisher, Reed and Addonizio, 1981). Studies of
halothane-induced ATP depletion in p la te le ts  have produced 
c o n f l ic t in g  re s u lts .  One study reported a s ig n if ica n t decrease of 
ATP in MHS p la te le ts  when compared with controls (Solomons, McDermott 
and Mahowald, 1980) but another study observed no d ifference (Giger
and Kaplan, 1983). The most commonly studied serum enzyme in MH was
CPK which was elevated in approximately 70% of MHS ind iv idua ls  (Blank
and Gruener, 1983). Evaluation of CPK levels as a screening method
fo r  MH in an ambulatory surgical pa tient population showed a poor 
co rre la t io n  between high serum CPK and s u s c e p t ib i l i ty  to MH 
(Amaranath, Lavin, Trusso and Boutros, 1983). Typing of the human 
leukocyte antigen in a single MHS fam ily  showed no diagnostic value 
(Lutsky, Witkowski and Henschel, 1982).
Anthropometric studies ( tha t i s ,  he ight, weight and sk in fo ld  
thickness) have been shown to be of no diagnostic value in MH 
(Campbell, E l l i s ,  Hal sal 1 and Hogge, 1982).
1.7 Syndromes Related to  Malignant Hyperpyrexia 
Malignant hyperpyrexia usually presents c l in ic a l l y  in susceptible 
ind iv idua ls  when anaesthesia is  induced with drugs which t r ig g e r  MH. 
I t  may also present, however, as heat-stroke a fte r  severe physical 
stress (Denborough, 1982) or rhabdomyolysis a fte r  serious in fec tions 
(Denborough, C o ll ins  and Hopkinson, 1984). In the case of
heat-stroke, dantrolene sodium has been shown to be an e ffe c t ive  
treatment (Denborough, 1982; Lyd ia tt and H i l l ,  1981). An association 
between MH and the sudden in fan t death syndrome (SIDS) has also been 
described (Denborough, Galloway and Hopkinson, 1982). In th is  study
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5 out of 15 parents whose children had died from SIDS were ident if ied  
as MHS.
1.8 Malignant Hyperpyrexia in Animals
Malignant hyperpyrexia has been iden t i f ied  in pigs (Hall, Woolf, 
Bradley and Jo l ly ,  1966), cats (De Jong, Heavner and Amory, 1974), 
dogs (Short and Paddleford, 1973) and horses (Williams, 1976).
Porcine MH has become the animal model of human MH with _in_ vitro 
pharmacological studies of skeletal muscle showing identical 
behaviour in both species (Okumura, Crocker and Denborough, 1979).
The MH suscep t ib i l i ty  found in pigs is  associated with two other 
conditions resul t ing from interbreeding. These are the porcine 
s t ress  syndrome (PSS) and the pale, so f t ,  exudative pork syndrome 
(PSEP). Porcine s t ress  syndrome is  induced by stresses such as 
f ighting or t ransporta t ion and i t s  symptoms include shortness of 
breath, increasing body temperature, patchy cyanosis of the skin and 
collapse and death within a few minutes (Topel, Bicknell, Preston, 
Christian and Matsushima, 1968). Pale, sof t ,  exudative pork syndrome 
refers to poor meat quality post-mortem and is  a feature of fas t  
glycolysing muscle which produces large quanti t ies  of lac ta te  before 
the muscle can be cooled (Briskey, 1964). I t  appears that  MH, PSS 
and PSEP are d i f fe ren t  manifestations of the same syndrome in swine 
(Nelson, 1973).
1.9 The Aetiology of Malignant Hyperpyrexia
The major p rec ip i ta t ing  event when a MHS individual or MHS pig is 
administered halothane appears to be a sudden r i se  in the myoplasmic
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Ca^+ concentration (Britt, 1983; Denborough, 1980). The basic
abnormality in MH muscle accounting for this rise has yet to be
elucidated although a number of possibili t ies have been suggested.
These included an abnormality of excitation-contraction coupling (E-C
coupling) (Denborough, 1980; Okumura, Crocker and Denborough, 1980),
an abnormality of Ca uptake by the sarcoplasmic reticulum (SR)
(Gronert, Heffron and Taylor, 1979; Blank, Gruener, Suffecool and
2+Thompson, 1981), an abnormality of Ca release by the SR (Nelson, 
1983; Ohnishi, Taylor and Gronert, 1983), defective Ca^+ storage by 
the mitochondria (Cheah and Cheah, 1978, 1979), or an increased
adenylate cyclase activity with a resulting increase in cyclic-AMP 
levels (Willner, Cerri and Wood, 1981).
2+Whatever the basic cause, a rise in myoplasmic Ca will have
multiple heat-producing effects. Phosphorylase will become activated
leading to the breakdown of glycogen to lactic acid, carbon dioxide
and heat. Actomyosin ATPase will become activated and hydrolyze ATP
to ADP, phosphate, heat, and energy which is utilized in muscle
2+contraction. Ca will also bind to troponin C init iat ing
2+contraction. The elevated levels of Ca reached in MHS muscle 
during a MH episode cause further problems in the mitochondria. 
Oxidative phosphorylation is uncoupled from electron transport, 
thereby decreasing ATP production and further exacerbating oxygen 
consumption and lactate, carbon dioxide and heat output. Muscle ATP 
levels fall rapidly once the stores of high energy creatine phosphate 
have been exhausted, and enzymes util izing ATP as an energy source no 
longer function efficiently. These enzymes include the sarcolemmal 
ATPases which ensure a favourable intracellular environment. Ions
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and molecules d if fu se  in to  and out of the muscle c e l l .  Calcium ions 
flow  in to  the ce l l  fu r th e r  exacerbating the s itua t ion . Once the
sarcolemma has been breached, enzymes and myoglobin leak outward, and 
myoglobin can obstruct the renal tubules and cause renal fa i lu re .  
The changes produced in serum pH and e le c tro ly te  balance can act on 
body tissues and cause haemolysis, consumption coagulopathy, and 
cardiac arrhythmias ( B r i t t ,  1983; Denborough, 1980).
1.10 The S ite of the Basic Abnormality in Malignant Hyperpyrexia 
1.10.1 Skeletal Muscle and Malignant Hyperpyrexia 
I t  is  accepted tha t skeletal muscle is  the s ite  of the basic 
abnormality in  MHS ind iv id ua ls . This b e l ie f  was based, in the f i r s t  
instance, on a number o f c l in ic a l  observations of MH episodes. 
During a MH c r is is  the skeletal musculature of many patients displays 
a generalized r i g i d i t y .  The serum leve ls of muscle spec if ic  enzymes 
such as CPK show dramatic increases, ind ica ting  muscle damage ( B r i t t ,  
1979). Also the observation that in the face of generalized r i g id i t y  
during a MH episode a limb to which a tourniquet had been applied 
early  in anaethesia remained f la c c id ,  indicated that the anaesthetic 
was a ffec ting  skeletal muscle (Drury and Gilbertson, 1970). I t  was 
also found tha t some MHS ind iv idua ls  showed c l in ic a l l y  discernable 
myopathies (Denborough, Ebeling, King and Zapf, 1970; King,
Denborough and Zapf, 1972; Denborough, Dennett and Anderson, 1973; 
Moulds and Denborough, 1974d) and that approximately 70% of 
susceptible ind iv idua ls  have an elevated resting serum CPK (Isaacs 
and Barlow, 1970). Following these observations, in v i t ro
pharmacological studies of skeletal muscle from MHS ind iv idua ls  have 
shown an abnormal c o n t r a c t i l i t y  of th is  tissue (Kalow, B r i t t ,  Terreau
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and Hai s t,  1970; E l l i s ,  Keaney, Harriman, Sumner, Kyei-Mensah, 
T y r re l l ,  Hargreaves, Parikh and Mulrooney, 1972; Moulds and
Denborough, 1974a). Before going on to describe the pharmacological 
and biochemical f ind ings in MH muscle the structure and biochemistry 
of skeletal muscle w i l l  be b r ie f ly  reviewed.
1.10.2 Structura l Organisation of Skeletal Muscle
1.10.2.1 Macroscopic Organization
Skeletal muscle accounts fo r  40-50% of to ta l mammalian body weight, 
and i t s  specialized function is  to convert chemical energy in to 
co n tra c t i le  fo rce. The muscle consists of a large number of muscle 
f ib re s  which are elongated, multinucleate ce l ls  running from one end 
of a muscle to the other. These f ib re s  can be 10 cm or more in 
length and th e ir  diameters range from 10-100 jjm. Individual f ib res  
are separated from th e ir  neighbours by a f in e  network of collagen 
f i b r i l s  called the endomysium. Groups of muscle f ib re s ,  or 
fasc ic le s , are divided from one another by another collagen layer 
called the perimysium, and f i n a l l y  the whole muscle is  enclosed in a 
strong collagen coat, the epimysium.
1.10.2.2 Microscopic Organization
The plasma membrane of a muscle f ib re  is  referred to as the 
sarcolemma. The c o n tra c t i le  elements, the m yo fib r i ls ,  take up 85-90% 
of the f ib re  volume. They are surrounded and bathed by the 
sarcoplasm, the in t ra c e l lu la r  f lu id  of muscle. The sarcoplasm 
contains glycogen, g ly c o ly t ic  enzymes, ATP, phosphocreatine and 
inorganic e le c tro ly te s ,  as well as a number of amino acids and 
peptides. Mitochondria, which are very profuse in more active
muscles, are regularly arranged along the myofibrils. The muscle 
fibre also contains a highly differentiated endoplasmic reticulum 
known as the sarcoplasmic reticulum (SR) which functions in the 
control of contraction as a store of Ca (Figure 1.1). The
t-tubules, invaginations of the sarcolemma, form junctions with the 
terminal cisternae of the SR (triad junctions) (Figure 1.1).
The myofibrils are irregular polygons in cross-section with a mean 
diameter of 1 pm and of indefinite length. They are composed of
serially repeating segments, the sarcomeres, the lateral alignment of 
which gives rise to the characteristic cross striations of the whole 
fibre (Figure 1.2). The light bands are called isotropic or I bands, 
and the dark bands are called anisotropic or A bands. In resting 
muscle, the A bands are approximately 1.6 pm long and the I bands 
approximately 1 pm long. The I bands are bisected by a dense
o
transverse line about 800 A wide known as the Z line. The central 
portion of the A band, approximately 0.5 pm wide, called the H zone 
and less dense than the rest of the A band, is bisected by another 
dense, transverse line, the M line. The serially repeated unit, the 
sarcomere, extends from Z line to Z line (Figure 1.2) (Landon, 1982).
Electronmicroscopic examination of the myofibril in cross-section has 
shown that i t  is made up of many parallel myofilaments (Huxley and 
Hansen, 1954). The H zone has a hexagonal array of thick filaments 
(15-18 nm in diameter). The I band, on the other hand, displays a 
less regular array of thin filaments (7nm in diameter). In the 
denser parts of the A band both filament types are present, each 
thick filament surrounded by six thin filaments (Figure 1.2). The
Figure 1.1 Schematic Diagram of Muscle Cell Structure 
From Bloom and Fawcett (1975).
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Figure 1.2 Diagram of the Structure of the Myofibrils.  
From Bloom and Fawcett, (1975).
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th ic k  filaments extend throughout the A band, and the th in  filaments 
extend from the Z l in e  to the H zone boundary. The overlap of the 
two fi lam ent types gives r ise  to the denser parts of the A band. In 
these denser regions regu la r ly  disposed cross-bridges between the 
th ic k  filaments and adjacent th in  filaments have been observed. 
These cross-bridges pro ject from the th ick  filaments (Sjostrom and 
Squire, 1977). During contraction the I band and H zone are 
shortened while the A band length remains unchanged. Observations 
such as these led to the formulation of the s l id ing -f i lam en t theory 
of muscle contraction (Huxley and Hansen, 1954; Huxley and 
Niedergerke, 1954). In th is  theory, changes in the length of a 
muscle are due to the s l id ing  of the th ick  and th in  filaments past 
each other due to th e i r  in te rac tion  through the cross-bridges.
1.10.2.3 Molecular Organization
The th ick  filaments are composed almost e n t ire ly  of the protein 
myosin. The myosin molecule is  rod shaped (approximately 150 nm 
long) with a molecular weight (MW) of 470,000. I t  is  made up of two 
strands forming an alpha-helix and bears two pear-shaped heads at one 
end ( E l l io t  and O ffer, 1978). The shafts of the myosin molecules 
stack together to form the shaft of the th ick  filament in such a 
manner that the paired heads l i e  on i t s  surface, and the myosin 
molecules in each ha lf  of each th ick  filament are arrayed with 
opposite p o la r i t ie s  (Figure 1.3a) (Huxley, 1963). The myosin heads 
correspond to the crossbridges seen between the th ick  and the th in  
f i lam ents. The th in  filaments are composed mainly of ac tin . The 
actin  monomer (G actin) is  a globular molecule (diameter 5.46 nm) 
with a MW of 45,000. These monomers form a filamentous polymer (F
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actin), a right handed, two stranded helix (diameter 6-7 nm) twisted
so that there are 13-15 6 actin molecules for every full rotation of
the helix (Huxley and Brown, 1967). A second thin filament protein,
tropomyosin, lies in the grooves on either side of the two chains of
actin molecules (Figure 1.3b). Tropomyosin is a rod shaped,
left-handed alpha-helix 38.5 nm long with a MW of 63,000. These
molecules lie head to tail along the length of the thin filament
(Cohen, Caspar, Parry and Lucas, 1971; Ebashi, 1980). The third thin
filament protein is troponin. This structure is globular with a MW
of about 80,000 (Ebashi, Kodama and Ebashi, 1968). One troponin unit
is attached to each tropomyosin molecule to give a periodicity of
38.5 nm along the thin filament (Ohtsuki, 1975). Troponin itself is
made up of three subunits, I, C and T. Troponin T binds the structure
to tropomyosin, troponin I inhibits the interaction of the thick
filament cross-bridges with the thin filament, and troponin C confers
Ca“+ sensitivity on this inhibition (Potter and Gergely, 1974). The 
2+binding of Ca to troponin C allows interaction between the thick 
and thin filaments, and thus allows contraction to proceed (assuming 
energy is avai 1 able).
1.10.3 The Control of Contraction in Skeletal Muscle
2+In resting muscle the Ca concentration in the sarcoplasm is in the 
range 10~^-10"^ M (Ashley, 1978), intracellul ar Ca^+ being
sequestered by the SR. This concentration gradient is upheld by a
2+ 2+ Ca -dependent transport ATPase present in the SR membrane. The Ca
2+is stored within the SR bound to a high capacity, low affinity Ca 
binding protein, calsequestrin (Otswald and MacLennan, 1974). When
1 6 .
b )
Troponin
Tropomyosin
Figure 1.3 Schematic Diagram of Thick and Thin Filament Structure.
a) Thick filament composed of myosin molecules.
b) Thin filament composed of ac tin , tropomyosin and 
tropon in .
From Bourne (1972).
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the innervating motor-neuron stimulates the muscle ce l l  to contract 
( tha t i s , -  releases acetylcholine at the motor endplate) the 
sarcolemma becomes depolarized. This trans ien t depolarization (from 
a resting level of -90 mV to -50 mV), resu lt ing  from a voltage and 
time-dependent increase in sodium conductance, spreads over the 
sarcolemma and t-tubu les  in to  the in te r io r  of the f ib re  (Nastuk and 
Hodgkin, 1950). Here the t- tubu les  form th e ir  t r ia d ic  junctions with 
the SR (Figure 1.1) and through an unknown coupling mechanism
stimulate the SR to release i t s  stored Ca (Costantin, 1975). When
2+the nervous stim ula tion ceases, release ceases, the Ca -dependent
2+transport ATPase can again reduce the sarcoplasmic Ca concentration 
and the f ib re  relaxes (Martonosi, 1982).
The nature of the coupling between the t- tubu le  and the SR at the
t r ia d  junction (exc ita t ion -con trac t ion  or E-C coupling) has received
o
much inves tiga tion . I t  is  known that the junctiona l gap (100-200 A
wide) is  bridged by regu la rly  disposed densities termed SR feet
(Franzini-Armstrong, 1980). Schneider and Chandler (1973) proposed
tha t charge movement w ith in  the t- tu b u le  membrane d ire c t ly  e ffects
2+the SR membrane permeability to Ca , the fee t acting as the l in k
between the two. Mathias, Levis and Eixenberg (1980), on the other
hand, envisaged a permeability channel spanning the en tire  junctiona l
gap. The t- tu b u le  depolarization led to i t s  t ra n s ito ry  opening and
subsequently to the in i t ia t io n  of a voltage-dependent increase in
2+permeability to Ca of the SR membrane. Other theories of E-C 
coupling in skeletal muscle provide no e x p l ic i t  ro le  fo r  the SR fee t.  
The most important among these is  the ' t r ig g e r '  Ca theory (Endo, 
Tanaka and Ogawa, 1970; Frank, 1982). This theory holds tha t a
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2+release of a small amount of Ca from the t- tubu le , e ither bound to
the membrane surface or w ith in  the tubule, leads to the release of
2+la rger amounts of Ca from the SR i t s e l f ,  thus in i t i a t in g  
con trac t ion .
1.10.4 The Source of Energy fo r  Contraction in Skeletal Muscle
The energy required by skeletal muscle to generate co n tra c t i le  force 
is  provided by ATP. The s l id in g  of the th ick  and th in  filaments past 
one another is  accomplished by the cyc l ica l attachment and release of 
the cross-bridges and is  driven by an ATPase enzyme w ith in  the myosin 
molecule (Huxley, 1962). The amount of ATP stored in muscle can 
sustain contraction fo r  only a f ra c t io n  of a second. High energy 
phosphoryl groups are stored in the form of phosphocreatine. This 
compound replenishes the ATP supply through the action of CPK.
Phosphocreatine + ADP ^  ATP + creatine 
As phosphocreatine stores are depleted the level of ATP f a l l s  and the 
levels of ADP and P.. r is e .  The level of AMP also rises through the 
action of adenylate kinase.
2 ADP 5=* ATP + AMP
The resu lt ing  f a l l  in the muscle ce ll energy charge stimulates 
g lyco lys is , the c i t r i c  acid cycle and oxidative phosphorylation. The 
re la t iv e  con tr ibu tion  of these pathways to ATP generation depends on 
the type of muscle examined.
1.10.5 Dantrolene Sodium and Skeletal Muscle
Dantrolene sodium (DANTRIUM, Norwich Pharmaceuticals) is  a l i p id  
soluble hydantoin de riva tive  (Snyder, Davis, Bickerton and Halliday,
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1967). I t  is a skeletal muscle relaxant which acts directly on
muscle (Ellis, Castellion, Honkomp, Wessels, Carpenter and Halliday, 
1973) and is thought to inhibit E-C coupling (Ellis and Bryant,
1972). Dantrolene sodium has been shown to lower resting myoplasmic
2+ 2+Ca concentrations and to inhibit the release of Ca from the SR in
intact cells,  (Desmedt and Hainaut, 1977, 1979), but i t  did not
2+ 2+ stimulate the Ca -dependent ATPase of isolated SR or affect Ca
exchange or efflux rates of isolated SR (White, Collins and
Denborough, 1983).
1.11 Calmoduli n
1.11.1 Introduction
2+Over 40 years ago Heilbrunn (1943) considered that Ca played a
central role in almost every physiological process. Although today
2+i t  -is known that Ca does not play as universal a role as Heilbrunn 
2+suggested, Ca exerts a profound influence on many biological
processes such as cell motility, muscle contraction, axonal flow,
cytoplasmic streaming, chromosome movement, neurotransmitter release,
endocytosis and exocytosis. Since 1970 i t  has become clear that many
2+of the cellular effects of Ca are mediated through a primary
2+receptor protein, the Ca -dependent modulator protein, calmodulin.
1.11.2 Biological and Physiochemical Properties of Calmodulin 
Calmodulin is a small, monomeric protein composed of 148 amino acids 
(MW approximately 17,000) (Watterson, Sharief and Vanaman, 1980). It  
is a highly conserved protein occurring in all the eukaryotic cells 
that have been examined (Cheung, 1980). Calmodulins isolated from 
various vertebrate sources and tissues appear to be identical
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proteins (Watterson, Mendel and Vanaman, 1980; Kakiuchi, Sobue, 
Yamazaki, Kambayashi, Sakon and Kosaki, 1981). Plant and
invertebrate calmodulins show only minor variations in amino acid 
composition (Grand, Nairn and Perry, 1980; Yasawa, Sakuma and Yagi, 
1980). Calmodulin has a high content of acidic amino acids 
(isoelectric point approximately 4.0) and a trimethylated lysine 
residue at position one hundred and fifteen (Watterson, Sharief and 
Vanaman, 1980). Another property of calmodulin, which is frequently 
exploited in isolation procedures, is i t s  remarkable heat stabili ty 
(Scharff, 1981).
2+Calmodulin appears to be related to other Ca -binding proteins such
as troponin C and parvalbumin. The conservative replacement sequence
homology between calmodulin and troponin C is approximately 70% and
2+is  particularly strong between the Ca binding domains of these two 
proteins (Dedman, Jackson, Schreiber and Means, 1978).
2+Calmodulin was f i r s t  identified as a Ca -dependent activator protein 
of a brain 3'-5' cyclic nucleotide phosphodiesterase (Cheung, 1980). 
Since that time i t  has been found to function in many cellular 
processes as a mediator of Ca effects (Table 1.1). Calmodulin by
i t s e l f  is not biologically active. The active form is the
2+ ?+Ca -calmodulin complex with calmodulin having four Ca binding
74 -sites (Wolff, Poirier, Brostrom and Brostrom, 1977). These Ca
binding sites share a common protein backbone configuration with the 
2+Ca binding sites of troponin C and parvalbumin which was termed the
"E-F hand" by Kretsinger and Barry (1975; Kretsinger, 1980). This 
2+Ca binding, which has been reported as cooperative (Crouch and
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Klee, 1980), induced a conformational change exposing a hydroDhobic 
surface on the calmodulin molecule (La Porte, Wierman and Storm, 
1980). This Ca -induced hydrophobic s i t e  may be the means by which 
calmodulin binds to i t s  effector  proteins and thereby exerts i t s
o+
action. In some cases calmodulin exerts i t s  Ca -dependent effects  
as a non-dissociable subunit of an enzyme, for example, phosphorylase 
kinase of skeletal muscle (Cohen, Burchell, Foulkes, Cohen, Vanaman 
and Nairn, 1978).
Some of the c e l lu la r  functions with which calmodulin has been
iden t i f ied  are shown in Table 1.1. Not all ce l ls  will express all  of
these functions simultaneously. Coordinate modulation of
calmodulin-dependent functions might be achieved in a number of ways
including variations in the a f f in i ty  of the effector  proteins of
2+calmodulin for  the Ca -calmodulin complex. The occupancy s ta te  of 
2+the four Ca binding s i te s  may also be important (Crouch and Klee,
2+1980). The concentration of the Ca -calmodulin complex i t s e l f  i s
2+affected by f luctuat ions in the levels of ce l lu la r  Ca , and perhaps 
by variations in the rates of synthesis and/or degradation of 
calmodulin. Cycl ic-AMP-dependent phosphorylation of membranes 
induced the release of calmodulin from the membrane (Hanbauer, 
Pradham and Yang, 1980) and also increased the binding of calmodulin 
to membrane-bound phosphodiesterase (Clayberger, Goodman and 
Rasmussen, 1981). The modulation of cell function by Ca and i t s
in terac t ions with cyclic-AMP mediated systems have been extensively 
reviewed by Rasmussen and Waisman (1983).
2 4 .
1.11.3 Calmodulin in Skeletal Muscle
Calmodulin is  present in  skeletal muscle at a concentration of
approximately 3 jjg/g tissue (Yagi, Yazawa, Kakiuchi, Oshima and
Uenishi, 1978). Immunocytochemical techniques have shown that i t  is
loca lized mainly at the level of the I bands and in the terminal
cisternae (Harper, Cheung, Wallace, Levine and Steiner, 1980).
2+Unlike cardiac SR, however, regulation of the Ca -ATPase of skeletal
muscle SR did not appear to involve calmodulin (Chiesi and Cara fo li,
1982). The spec if ic  function of calmodulin in skeletal muscle
2+appears to be the regulation of Ca -dependent protein
phosphorylation. Calmodulin has been shown to activate three protein 
kinases in th is  t issue , phosphorylase kinase, myosin l ig h t  chain 
kinase (MLCK), and an undefined protein phosphorylation system that 
has been recently  described (Campbell and MacLennan, 1982).
Phosphorylase kinase is  involved in the metabolism of the muscle
glycogen stores. I t  activates glycogen phosphoryl ase, the enzyme
which libera tes glucose-1-phosphate from glycogen. Phosphorylase
kinase phosphorylates the inactive  phosphorylase b to the active
2+phosphoryl ase a. This kinase a c t iv i t y  is  modulated by Ca -leve ls
through calmodulin which is  bound as a non-dissociable subunit of the
enzyme (Cohen, Burchell, Foulkes, Cohen, Vanaman and Nairn, 1978).
In rabbit skeletal muscle the regulation of the red muscle isozyme of
2+phosphorylase kinase by Ca was mediated by the t ig h t ly  bound
calmodulin subunit and was insens it ive  to exogenous calmodulin. The
24-white muscle phosphorylase kinase isozyme was also regulated by Ca 
through i t s  calmodulin subunit, but exogenous calmodulin provided 
additional Ca -dependent ac tiva tion  of the enzyme (Wang, Tam, Lewis
2 5 .
and Sharma, 1981). This additional ac tiva tion  of phosphorylase
kinase in white muscle (fas t tw itch) may help in the quick response
2+to increases in c e l lu la r  Ca needed in fas t muscle contraction.
Myosin l ig h t  chain kinase is  responsible fo r  the phosphorylation of a 
low MW component of myosin (Mayr and Heilmeyer, 1983). This 
component is  one of three myosin " l ig h t  chains" which can be 
separated from native myosin by polyacrylamide gel electrophoresis in 
the presence of sodium dodecyl sulphate (SDS) (Perrie, Sm ill ie  and 
Perry, 1973), and is  referred to as Ml9, g  ^ or P l ig h t  chain.
In smooth muscle the phosphorylation of th is  l ig h t  chain is  essential 
fo r  contraction (Sparrow, Mrwa, Hofmann and Ruegg, 1981). In 
skeleta l muscle, however, th is  is  not the case and a ro le fo r  MLCK 
phosphorylation of the l ig h t  chain has not been found. Cycles of 
phosphorylation and dephosphorylation of th is  l ig h t  chain have been 
observed in response to contraction and re laxation in whole skeletal 
muscle (Manning and S tu l l ,  1979). Crow and Kushnerick (1982) have 
proposed that l ig h t  chain phosphorylation may regulate the rate of 
cross-bridge turnover, but Bu tle r, Siegman, Mooers and Barsotti 
(1983) disputed th is .  Whatever the function of MLCK, i t  is  regulated 
by calmodulin. In the absence of calmodulin MLCK is  inac t ive , while 
in the presence of 1 mole o f calmodulin/mole of MLCK, 80-90% of 
maximum a c t iv i t y  is  obtained (Perry, Grand,Nairn,Vanaman and Wall, 
1979).
The th ird  and most recently described calmodulin-dependent protein 
kinase system in skeletal muscle is  located in the SR membrane. 
Campbell and MacLennan (1982) reported the calmodulin-mediated
26.
phosphorylation of two SR proteins of MW 20,000 and 60,000. They
concluded that this calmodulin-dependent phosphorylation may have
some role in Ca release from the SR. Chiesi and Carafoli (1982)
found three SR proteins in which phosphorylation was promoted by
calmodulin. The MW's of these proteins were 57,000, 35,000 and
20,000. These authors also found that calmodulin-mediated
2+phosphorylation of these proteins had no effect on Ca uptake by SR 
vesicles. They too concluded that this phosphorylation system may 
regulate Ca release from the SR. Further investigation (Chiesi and 
Carafoli, 1983) showed that none of the three proteins interacted 
directly with calmodulin, and that the calmodulin-dependent protein 
kinases involved were membrane bound.
1.11.4 Pharmacological Antagonism of Calmodulin Function
It is possible to antagonize the actions of calmodulin by the use of
certain classes of clinically used antipsychotic drugs (Levin and
Weiss, 1979). More recently, other types of drugs (such as R24571, a
derivative of an antimycotic) have been shown to be effective
calmodulin antagonists (Table 1.2) (Gietzen, Wuthrich and Bader,
1981). These agents have been used extensively as probes to
elucidate calmodulin functions and have proved to be a major
2+development in the study of this Ca -regulatory protein. However, 
as stated by Roufogalis, Minocherhomjee and Al-Jobore (1983), 
"currently available calmodulin antagonists are neither selective nor 
specific, despite their usefulness when used appropriately".
Trifluoperazine (TFP; STELAZINE, Smith Kline and French) (Figure 1.4) 
and related phenothiazines were shown to inhibit calmodulin-dependent
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Figure 1.4 The Structure of Trifluoperazine
2 9 .
forms of cyclic-AMP phosphodiesterase (Weiss, F e rte l,  F ig l in  and
Uzunov, 1974; Levin and Weiss, 1976), and i t  was la te r  shown that
th is  in h ib i t io n  was achieved through the in te raction  of the drugs
w ith  calmodulin ra ther than phosphodiesterase (Levin and Weiss, 1977,
1979). The binding of TFP to calmodulin was observed to be 
2+Ca -dependent at low concentrations of drug and enhancement of 10 to
100-fold was obtained in the presence of 100 j j M Ca (Levin and
Weiss, 1977). T r i f 1uoperazine concentrations of the order of 100 j j M,
however, led to Ca -independent binding (Levin and Weiss, 1978). 
2+The Ca -dependent binding of TFP to calmodulin appeared to involve
two high a f f in i t y  s ites (Kd = 1-1.5 jjM ) while Ca2+-independent
binding involved a large number of low a f f in i t y  s ites (Kd = 5 mM)
(Levin and Weiss, 1977, 1978). Other d iva lent cations which
substituted fo r  Ca^+ were Sr^+ >  Ni^+ >  Co^+ >  Mn^+, while Ba^+ 
2+and Mg were in e f fe c t iv e  (Levin and Weiss, 1977).
Levin and Weiss (1978) have described the s e le c t iv i ty  of low
concentrations of TFP fo r  calmodulins isolated from various sources
2+and a series of other Ca binding proteins including myosin l ig h t
chain, phospholipases A and B, S-100 protein and troponin C. They
observed a s im ila r amount of TFP binding to a l l  the calmodulins
2+tested. Among the other Ca binding proteins only troponin C bound 
TFP to any s ig n if ic a n t  extent (approximately one tenth of the amount 
of TFP bound to calmodulin). At concentrations of TFP above 10 j j M or 
at a pH above 8 the extent of TFP binding was s im ila r fo r  both 
troponin C and calmodulin.
30 .
The structural specificity of the phenothiazine-calmodulin
interaction was investigated by Roufogalis (1981). Four analogues of
chiorpromazine, differing in the position of chlorine substitution on
the aromatic ring were almost equally potent in antagonizing
calmodulin activation, while only the two-chloro analogue possessed
tranquilizer activity.  Roufogalis concluded that the
phenothiazine-calmodulin interaction was structurally non-specific.
Norman, Drummond and Moser (1979) have reported that the property of
calmodulin antagonists which correlated best with their potency as
inhibitors was their octanol/water partition coefficients (degree of
hydrophobicity). This observation is consistent with the findings of
La Porte, Wierman and Storm (1980) that the binding of Ca to
calmodulin brought about the exposure of a hydrophobic region on this
protein. Presumably this is the si te of calmodulin binding to i ts
2+effector enzymes and also the si te of Ca -dependent antagonism by 
drugs.
Due to the hydrophobicity of the calmodulin antagonists, these drugs 
may have other sites of action besides calmodulin i t s e l f .  The most 
important of these may be their partitioning into membrane lipid and 
interaction with the hydrophobic domains of membrane proteins (Corps, 
Hesketh and Metcalf, 1982; Guth and Spirtes, 1964; Frisk-Holmberg and 
Kleijn, 1972; Seeman, 1972). Recently a number of reports have shown 
direct effects of calmodulin antagonists on enzyme activity in the 
absence of calmodulin. Vincenzi, Adunyah, Niggli and Carafoli (1982) 
observed that TFP as well as a number of other calmodulin antagonists 
were inhibitory to the red blood cell plasma membrane ATPase 
reconstituted into lipid vesicles both in the presence and absence of
calmodulin. Louis, Turnquist and Jarvis (1983) have shown an
in h ib i t io n  of calmodulin-dependent and calmodulin-independent cardiac
SR functions by R24571 . Schatzman, Wise and Kuo (1981) suggested
tha t TFP and other calmodulin antagonists were in te rac ting  with
phospholipid to produce in h ib i t io n  of a phospholipid-sensitive 
2+Ca -dependent protein kinase.
Perhaps some of the disadvantages of the curren tly  available 
calmodulin antagonists may be overcome, at least in  sub-ce llu la r 
systems, by the use of a new form of antagonist. Newton and Klee 
(1984) have reported the use of CAPP-calmodulin, a calmodulin 
molecule with a phenothiazine molecule (norchlorpromazine) conjugated 
to i t ,  as a calmodulin antagonist. They observed potent competitive 
antagonist a c t iv i t y  fo r  phosphodiesterase and myosin l ig h t  chain 
kinase. The inherent s e le c t iv i ty  of the inactive CAPP-calmodulin 
conjugate fo r  calmodulin binding s ites may lessen many current 
problems of s p e c i f ic i t y .
1.12 Pharmacological Findings in Malignant Hyperpyrexia 
Susceptible Muscle
Muscle biopsy specimens from MHS ind iv idua ls  and MHS swine display 
abnormal contracture responses to a varie ty  of chemical s t im u li .  
Halothane and succinylcholine (ANECTINE; Wellcome Austra lia  Ltd) 
caused an increased contracture in MH muscle j_n v i t ro  when compared 
with control muscle (E l l i s ,  Keaney, Harriman, Sumner, Kyei-Mensah, 
T y r re l l ,  Hargreaves, Parikh and Mulrooney, 1972; Moulds and 
Denborough, 1974b, 1974c; Hal sa il and E l l i s ,  1979). Contractures
induced by caffe ine (Kalow, B r i t t ,  Terreau and Haist, 1970) and
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thymol (the preservative used in the commercial halothane
preparation) (Okumura, Crocker and Denborough, 1979) were also 
increased in MH muscle, as was the contracture produced by potassium 
chloride depolarization of the muscle cell membrane.
The increased contracture responses in MH skeletal muscle were
temperature-dependent (Kalow, B r i t t ,  Terreau and Haist, 1970; Nelson,
Austin and Denborough, 1977; Sullivan and Denborough, 1981). The
optimal temperature for  producing drug-induced contractures was 37°C.
At 22°C the drug-induced contractures were signif icant ly  reduced.
Both halothane and caffeine potentiated isometric twitch responses in
normal human muscle (Nelson and Denborough, 1977). The muscle
relaxant  dantrolene sodium prevented and reversed these drug-induced
contractures (Austin and Denborough, 1977). These resu l ts  suggested
tha t  drugs which produce abnormal contracture responses in MH muscle
2 +were causing an increase in the myoplasmic Ca concentration.
Dantrolene sodium was able to reverse the abnormal contractures by
2+decreasing the myoplasmic Ca concentration (B r i t t ,  1983; 
Denborough, 1980; Desmedt and Hainaut, 1977).
Attempts have been made to identify  the s i t e  of the abnormality in MH 
porcine muscle by treatments which inh ib i t  E-C coupling. Okumura, 
Crocker and Denborough (1980) found that  glycerine treatment of MH 
muscle, which physically disrupts the t- tubule  system, inhibited the 
abnormal drug-induced contractures to halothane, caffeine, 
succinylcholine and potassium chloride.  These authors also found 
that  pretreatment of MH muscle with deuterium oxide, which inh ib i ts  
E-C coupling, inhibited the abnormal contracture responses of MH
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muscle. These resu lts  suggested that the s ite  of the abnormality in
MH muscle l ie s  in the E-C coupling mechanism. Another investigation
?+in porcine MH muscle u t i l iz e d  the Ca antagonist 8-(N,N-
d ie thy lam ino)-oc ty l-3, 4, 5, -trimethoxybenzoate (TMB-8) (Sull ivan,
Galloway and Denborough, 1983). Low concentrations of TMB-8
in h ib ite d  potassium chloride-induced contractures but potentiated
contractures induced by halothane, caffeine and succinylcholine.
Higher concentrations of TMB-8 contracted MHS muscle but had l i t t l e
e f fe c t  on normal muscle. TMB-8-induced hyper-reac tiv ity  in MHS
muscle could be abolished by g lyce r in iza tion  or by dantrolene sodium.
2+Since TMB-8 had no e f fe c t  on Ca levels in ac tive ly  loaded MH muscle 
microsome preparations, the E-C coupling mechanism was again 
implicated as a probable s ite  of the MH abnormality.
Nelson and Schochet (1982) have proposed that MH may be a disease of 
spec if ic  myofibre type. They have shown that a porcine MH muscle 
with a high proportion of type I f ib re s  (trapezius) has a greater 
abnormal contracture response to halothane than one with a low 
proportion of type I f ib re s  ( g ra c i l is ) .
1.13 Biochemical Findings in Malignant Hyperpyrexia
1.13.1 Skeletal Muscle
1.13.1.1 The Sarcoplasmic Reticulum
The skeletal muscle SR is  the organelle which is  responsible fo r  the
24 -
uptake and storage of myoplasmic Ca*" , and fo r  the release of stored 
2+Ca to in i t i a t e  contraction and muscle ce l l  ac t iva t ion . Because of
2+i t s  central ro le  in muscle ce ll Ca metabolism a number of studies 
have investigated the function of the SR in MH muscle using isolated
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2+membrane preparations. Studies of Ca uptake by human MH muscle SR
preparations have been equivocal (Table 1.3). A reduction in the
2+Ca uptake ra te  by MHS SR preparations compared with control SR
preparations has been reported (B r i t t ,  Kalow, Gordon, Humphrey and
Rewcastle, 1973; Isaacs and Heffron, 1975). However, in other
2+studies no difference between Ca uptake in MHS and control
preparations has been found (Kalow, B r i t t ,  Terreau and Haist,  1970;
Dhalla, Sulakhe, Clinch, Wade and Naimark, 1972; Blanck, Gruener,
Suffecool and Thompson, 1981). Studies of the effect  of halothane on 
2+Ca uptake by MHS and control SR preparations have also produced
24-
mi xed re s u l t s .  In the presence of halothane, Ca uptake by MHS and
control SR preparations was unaffected (Isaacs and Heffron, 1975),
inhibited to a similar degree (Blanck, Gruener, Suffecool and
2+Thompson, 1981), MHS CaL uptake inhibited while control was not 
(B r i t t ,  Kalow, Gordon, Humphrey and Rewcastle, 1973; Kalow, B r i t t ,  
Terreau and Haist,  1970) and control inhibited more than MHS (Dhalla, 
Sulakhe, Clinch, Wade and Naimark, 1972).
2+Studies of porcine MHS SR Ca uptake have led to no firm conclusions 
(Table 1.3).  Ca uptake has been reported to be increased in MHS SR 
preparations when compared with controls (Berman and Kench, 1973; 
Brucker, Williams, Popinigis, Galvez, Vail and Taylor, 1973; B r i t t ,  
Endrenyi and Cadman, 1975), normal (Nelson, Jones, Venable and Kerr, 
1972; Denborough, Hird, King, Marginson, Mitchelson, Naylor, Rex, 
Zapf and Condron, 1973; White, Collins and Denborough, 1983) or 
decreased when compared with controls (McIntosh, Berman and Kench, 
1977; Nelson, 1978; Gronert, Heffron and Taylor, 1979). The 
presence of halothane has been reported to increase (Nelson, Jones,
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Table 1 .3
O i
Ca Uptake by M alignant H yperpyrexia S u s c e p t ib le  
S arcop lasm ic  Reticulum  P re p a r a t io n s  in  R e la t io n  to  
Control P rep ara tion s
Human
reduced B r i t t ,  Kalow, Gordon, Humphrey and Rewcas tle  (1973)
reduced I s a a c s  and Heff ron (1975)
si mil a r Kalow, B r i t t ,  Terreau  and H a i s t  (1970)
s i m i 1ar D h a l l a ,  Sulakhe ,  C l in ch ,  Wade and Naimark (1972)
si m i la r Blanck,  Gruener,  Suf fecoo l  and Thompson (1981) .
P o rc in e
reduced McIntosh,  Berman and Kench (1977)
reduced Nelson (1978)
reduced G r o n e r t ,  Heffron and Tay lor  (1979)
s i m i 1a r Nelson,  J o n e s ,  Venable and Kerr  (1972)
si mi 1 ar Denborough,  H ird ,  King, Marginson,  M itche lson ,  
N ay lo r ,  Rex, Zapf and Condron (1973)
si mil a r White,  C o l l i n s  and Denborough (1983)
in c r e a s e d Berman and Kench (1973)
in c r e a s e d B r i t t ,  Endrenyi and Cadman (1975)
in c r e a s e d Brucker ,  W i l l i ams ,  P o p i n i g i s ,  Galvez ,  Vail and Taylor
(1973)
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Venable and Kerr, 1972) and to decrease (Gronert Heffron and Taylor,
1979) Ca uptake by SR preparations from control and MHS porcine
muscle. In another study MH SR preparations were sensitive to
? +halothane inhibition of Ca uptake whereas control SR preparations
were not (Brucker, Williams, Popinigis, Galvez, Vail and Taylor,
1973). The rates of passive Ca efflux were similar in MH and
control SR preparations (White, Collins and Denborough, 1983). Two
2+ 2+recent studies showed abnormalities of Ca -induced Ca release from
MH SR preparations. Nelson (1983) and Ohnishi, Taylor and Gronert
(1983) observed that the average Ca concentration threshold for 
2+ 2+Ca -induced Ca release was markedly lower for MH heavy SR when 
compared with controls.
Studies on the effects of dantrolene sodium on SR function in porcine
2 +MH SR preparations showed no effect on Ca uptake (White, Collins 
and Denborough, 1983) but an inhibitory effect on halothane-induced 
calcium release (Ohnishi, Taylor and Gronert, 1983).
The phospholipid content of the SR of porcine MH muscle has been 
investigated by Jardon, Barak, Noffsinger, Chapin and Wingard (1980). 
These authors found a reduction in phosphatidylcholine and 
phosphatidyl ethanol amine in the SR of MH muscle when compared to 
control muscle SR.
1.13.1.2 Muscle Proteins
No specific muscle protein abnormalities have been reported in MHS 
tissue. Lorkin and Lehmann (1983a) used two dimensional gel 
electrophoresis to study whole muscle extracts, and EDTA and myosin
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l i g h t  chain extracts of control and MH porcine muscle. They found no 
obvious differences in the major co n tra c t i le  proteins or g lyco ly t ic  
enzymes. These authors (Lorkin and Lehmann, 1983b) have also studied 
troponin C (by t r y p t ic  peptide mapping) from control and MH porcine 
skeleta l muscle and found no differences.
1.13.1.3 Mitochondria
Cheah and Cheah (1978, 1979) proposed that an abnormality of
2+
mitochondrial Ca storage may be responsible fo r  porcine MH. They
2+found an increased Ca e f f lu x  rate in  mitochondria isolated from MHS
2+muscle, and considered that the released Ca was s u f f ic ie n t  to 
t r ig g e r  rapid g lyco lys is ,  ac tiva tion  of the m y o f ib r i l la r  ATPase and 
ac tiva t ion  of phosphorylase kinase.
1.13.1.4 Electrophysiology
Gallant, Godt and Gronert (1979) have observed that halothane 
depolarized the sarcolemma of MHS porcine muscle but not control 
muscle, and tha t dantrolene reduced or reversed th is  depolarization. 
The suggestion by these authors that the basic abnormality in MH 
involved the sarcolemma is  not supported by another investiga tion  
where no e f fe c t  of halothane on sarcolemmal resting membrane 
po ten tia l of MHS muscle was observed (Bradley, Ward, Murchison, Hall 
and Woolf, 1973).
The electromechanical studies of Nelson, Flewellen and Arnett (1983) 
showed that the time in te rva l from nerve stimulation to onset of 
mechanical tension was longer fo r  muscle from MHS pigs than fo r  
control muscle both in v i t r o  and in vivo. The in vivo k ine tics  of
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compound muscle action potential formation were similar in control 
and MHS muscle, but the interval from the peak of the muscle action 
potential to tension onset was longer in MHS muscle. These authors 
concluded tha t  these resu l ts  could have been explained by an 
abnormality of E-C coupling in MH.
1.13.1.5 Muscle Energy Metabolism
2+When MH skeletal muscle was exposed to halothane, myoplasmic Ca 
levels  rose and actomyosin ATPase was activated.  This led to a 
reduction in the creatine  phosphate concentration in MHS muscle much 
greater  than that  observed in control muscle. This applied to both 
human MHS muscle (B r i t t ,  Endrenyi, Kalow and Peters, 1957) and 
porcine MHS muscle (Harrison, Saunders, Biebuyck, Hickman, Dent, 
Weaver and Terblanche, 1969; Berman and Kench, 1973; Nelson, Jones, 
Venable and Kerr, 1972). Untreated human MHS muscle (Isaacs, Heffron 
and Badenhorst, 1975) and porcine MHS muscle (Van den Hende, Lis ter ,  
Muylle, Dorns and Oyaert, 1976) have also been shown to display 
reduced creatine phosphate levels .  The muscle enzyme CPK has been 
found to be elevated in the serum of many MHS individuals , due to 
leaky muscle membranes (B r i t t ,  1977).
A deficiency of adenylate kinase, the enzyme which catalyses the 
conversion of two molecules of ADP to one molecule of ATP and one 
molecule of AMP, has been reported in human MH (Schmitt, Schmidt and 
R i t te r ,  1974). Also, a binding s i t e  for halothane on the adenylate 
kinase molecule was reported by Sachsenheimer, Pai , Schulz and 
Schirmer (1977). Marjanen, Shaw and Denborough (1983) investigated
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the s tructure  and ac t iv i ty  of adenylate kinase in control and MH 
porcine muscle but fa i led  to find any differences.
Muscle phosphorylase, the enzyme which l ibera tes  glucose-1-phosphate
from glycogen, is  present in two forms. The a or active form and the
2+b or inactive form are interconverted by a Ca -dependent 
phosphorylase kinase. Willner, Wood, Cerri and Bri t t  (1980) observed 
the r a t io  of phosphorylase a to to ta l  phosphorylase in human MHS 
skeletal  muscle to be higher than control values. Such an imbalance 
might help fuel explosive glycolysis during a MH episode and 
contribute to l a c t i c  acid formation. Traynor, Van Dyke and Gronert 
(1983), however, found no s ignif icant  differences between the 
phosphorylase a to total  phosphorylase ra t io  in the muscle of the ir  
group of MHS subjects and controls.  Willner (1984) and Gronert and 
Van Dyke (1984) have discussed these d if fe ren t  findings.
1.13.1.6 Cyclic Nucleotides
An increase in the ac t iv i ty  of adenylate cyclase and high cyclic-AMP
levels  have been reported in human MHS skeletal muscle (Willner,
Cerri and Wood, 1981). These authors suggested that  these changes
may resu l t  in the observed increase in levels of phosphorylase
act ivation in human MHS muscle through act ivation of a cyclic-AMP
dependent phosphorylase kinase (Willner, Wood, Cerri and B r i t t ,
1980). Willner, Cerri and Wood (1981) also proposed that  increased
phosphorylation of SR proteins by cyclic-AMP dependent protein
2+kinases may contribute to abnormalities of SR Ca transport  in MHS 
muscle. Porcine MHS muscle has also been found to contain cyclic-AMP
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concentrations s ignif icant ly  higher than control at 3 minutes post 
mortem (Ono, Topel and Althen, 1976, 1977).
1.13.2 Other Tissues
1.13.2.1 P la te le ts
Rosenberg, Fisher, Reed and Adonizio (1981) have studied the
aggregation of p la te le t s  from MHS individuals. They found no 
consistent  or specific  difference in MH p la te le t  aggregation when 
compared to control p la te le t s .  Halothane-induced p la te le t  ATP 
depletion has also been investigated in human MH. Solomons, 
McDermott and Mahowald (1980) found a decrease in ATP in MH p la te le ts  
when compared to control ,  whereas Giger and Kaplan (1983) found no 
d i f fe rence .
1.13.2.2 Pancreas 
2+Since Ca is  also involved in the stimulus-secretion coupling of 
insul in  release from the pancreatic be ta -ce l l ,  Denborough, Warne, 
Moulds, Tse and Martin (1974) studied glucose-stimulated insulin 
secretion in MHS individuals . These authors observed an increased 
glucose-induced insulin  response in MHS individuals when compared to 
controls ,  and concluded that  the membrane abnormality of skeletal 
muscle in MH may be generalized.
1.13.2.3 Catechol amines
L is te r ,  Hall and Lucke (1974) and Gronert and Theye (1976) have
observed large increases in c ircu la t ing  catecholamine levels during
porcine MH episodes. These increases might be produced by a 
2+Ca -dependent release of catecholamines from the adrenal medulla
(Douglas and Rubin, 1961) and may contribute to the stimulation of 
heat production in MH (Denborough, 1980).
1.13.2.4 Erythrocytes
Lorkin and Lehmann (1983b) studied calmodulin of erythrocytes from 
contro l and MHS swine by two dimensional electrophoresis and found no 
d iffe rences.
1.4 Summary
Malignant hyperpyrexia is  a l i fe - th re a te n in g  reaction to general 
anaesthesia which occurs in ind iv idua ls  with an underlying muscle 
disease. The symptoms of MH include hyperpyrexia and r ig id i t y  of the 
skeleta l musculature. The muscle relaxant dantrolene sodium is  now 
availab le as a spec if ic  treatment of MH. The symptomology of MH and 
the i_n_ v i t ro  pharmacology of MHS skeletal muscle have suggested tha t
the basic abnormality in MH involves an abnormal regulation of
2+ 2+ myoplasmic Ca leve ls . Investigations of the Ca regulatory
functions of MHS skeletal muscle, however, have not shown a
consistent or spec if ic  abnormality in these functions. A number of
studies have implicated the E-C coupling mechanism as the s ite  of the
basic abnormality in MHS skeletal muscle.
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CHAPTER 2 THE PHARMACOLOGY OF CALMODULIN ANTAGONISTS IN  CONTROL AND 
MALIGNANT HYPERPYREXIA SUSCEPTIBLE PORCINE SKELETAL 
MUSCLE.
2.1 Introduction
Malignant Hyperpyrexia susceptible skeletal muscle exhib its
hyp e rco n t ra c t i l i t y  to 3% halothane, 2 mM caffe ine, 1 mM
succinylchol ine and 80 mM potassium chloride j_n vi t ro  in a
pharmacological muscle s t r ip  preparation (Okumura, Crocker and
Denborough, 1979). This hypercon trac t i l i ty  may be explained by an 
2+abnormality of Ca regulat ion in MHS muscle leading to a higher than
24-
normal myoplasmic Ca" concentration (Denborough, 1980). Since the 
2+Ca regulatory protein calmodulin has been implicated in many 
Ca -dependent processes (Chapter 1.11), i t s  possible ro le in MH was 
investigated.  In th is  chapter the possible role of calmodulin in 
producing the skeletal muscle hypercontrac t i l i ty  which is  
charac te r is t ic  of susce p t ib i l i t y  to MH was investigated. This was 
done by studying the effects  of calmodulin antagonist drugs on 
control and MHS porcine muscle c o n t r a c t i l i t y  in v i t r o .
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Table 2.1 The Calmodulin Antagonist Drugs used in the Present
Pharmacological Studies
O c t a n o l / W a t e r  
P a r t i t i o n  
C o e f f i c i e n t  
( S e e m a n ,  1 9 7 7 )
I r n  f o r  C a l m o d u l  i n 
5 0  (j j M)
P e n f l u r i d o l  ( P E N ) 4 0 , 0 0 0 , 0 0 0 2 . 5 L e v i n  a n d  W e i s s , 1 9 7 9
P i m o z i d e  ( P I M ) 2 , 0 0 0 , 0 0 0 7 L e v i n  a n d  W e i s s , 1 9 7 9
T r i f l u o p e r a z i n e  ( T F P ) 1 , 7 0 0 , 0 0 0 1 0 L e v i n  a n d  W e i s s , 1 9 7 9
F l u p h e n a z i n e  ( F P Z ) 9 1 2 , 0 0 0 1 0 R o u f o g a l i s ,  1 9 8 2
H a l o p e r i d o l  ( HPD) 5 5 5 , 0 0 0 6 0 L e v i n  a n d  W e i s s , 1 9 7 9
C h l o r p r o m a z i n e  ( C P Z ) 1 9 1 , 0 0 0 4 2 L e v i n  a n d  W e i s s , 1 9 7 9
P r o m e t h a z i n e  ( P R O) 2 2 , 4 0 0 3 4 0 W e i s s ,  P r o z i a l e c k  a n d  
W a l l a c e ,  1 9 8 2
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2.2 Materials and Methods
2.2.1 Drugs and Reagents
The following g i f t s  of drugs are gratefully  acknowledged: TFP from
Smith, Kline and French Laboratories Australia; PRO and CPZ from May 
and Baker Australia Pty Ltd; FPZ from E.R. Squibb and Sons; HPD 
from Searle Laboratories; PEN and PIM from Janssen Pharmaceutica, 
N.V., Belgium; and dantrolene sodium from Norwich Pharmaceuticals.
The drugs used in the pharmacological experiments and diagnostic 
te s t ing  were thymol-free halothane, kindly supplied by ICI Australia , 
and a pharmaceutical preparation of succinylcholine (ANECTINE, 
Wellcome Australia Ltd).
All other reagents were of analytical grade.
2.2.2 Experimental Animals
Malignant hyperpyrexia susceptible swine were bred from MHS stock and 
from crosses of MHS and non-affected stock. Control swine were 
ident i f ied  from mixed l i t t e r s  and also obtained commercially. The 
animals were housed at the Animal Breeding Establishment, Australian 
National University.
2.2.3 Anaesthesia
The animals were premedicated with 1.5-2 mg/kg of Stresnil (Smith, 
Kline and French Laboratories Australia Ltd) i ntramuscularly. 
Anaesthesia was induced with intravenous thiopentone (Pentothal 
Sodium, Abbott Hospital Products) at a dose of 6-8 mg/kg. 
Anaesthesia was maintained with 66% nitrous oxide in oxygen.
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2.2.4 Surgical Procedure
Muscle biopsy specimens were removed from the gracilis muscle. The 
specimens were 4 cm long, 1 cm wide and 0.5 cm thick and were held in 
clamps to maintain resting tension. Immediately after excision the 
specimens were placed into Ringer solution at 37°C which was bubbled 
with 5% carbon dioxide in oxygen (carbogen). The composition of the 
Ringer solution was 121 mM NaCl, 5.4 mM K Cl, 3.5 mM CaCl^, 1.2 mM Mg 
S0^, 1.2 mM NaH2 PO^ , 15 mM NaHCO^  and 11.5 mM glucose (pH 7.3).
2.2.5 The Organ Bath Preparation
Muscle fibre bundles of approximately 2 mm diameter were dissected 
from the biopsy specimen and small metal rings were attached to both 
ends of the bundle. This preparation was then suspended vertically 
in the organ bath (Figure 2.1). The muscle strip was attached at one 
end to a fixed glass rod and at the other to a Watson Victor force 
transducer (F.0202). When lowered into the organ bath, the muscle 
str ip  was bathed in 25 ml of Ringer solution continuously bubbled 
with carbogen. Signals from the force transducer were recorded using 
a Perkin-Elmer 56 chart recorder after amplification by a San-EI 6M51 
Strain Amplifier. After setting the init ial  resting tension for each 
muscle strip at approximately 1 g, the viability of the preparation 
was confirmed by 30V electrical stimuli.
Stock solutions of drugs and chemicals were: caffeine, 100 mM in 
Ringer; potassium chloride, 4M in Ringer; TFP, FPZ and PRO, 25 mM 
in Ringer; CPZ 25 mM in dist i l led water; HPD, PEN and PIM, 25 mM in 
dimethyl sulfoxide (DMSO); and dantrolene sodium, 15 mM in DMSO. 
Thymol-free halothane was administered by passing the carbogen 
through a Dragewick vapourizer.
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FORCE TRANSDUCER AMPLIFIER
PEN RECORDER
O R G A N  BATH - -
MUSCLE STRIP
Figure 2.1 Diagram of the Organ Bath and Associated Equipment.
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2.2.6 Data Storage and Analysis
Pharmacological tension responses were encoded and stored in a 
computer-based "S ta t is t ic a l  Package fo r  the Social Sciences" (Nie, 
H u l l ,  Jenkins, Steinbrenner and Bent, 1970). The data was analysed 
using Student's t - t e s t  with both pooled and separate variance 
estimates.
The mean contracture figures fo r  halothane, caffe ine, succinylcholine 
and potassium chloride of control and MHS muscle include diagnostic 
tes t in g  of pigs between April 1981 and April 1984.
Where exposure of the muscle to halothane, ca ffe ine , succinylcholine 
or potassium ch loride was preceded by treatment with a calmodulin 
antagonist, any contracture due to the calmodulin antagonist was not 
included in the subsequent measurement.
2.3 Results
2.3.1 Id e n t i f ic a t io n  of Control and Malignant Hyperpyrexia 
Susceptible Swine
The id e n t i f ic a t io n  of control and MHS swine was carried out in v i t ro  
using a muscle biopsy specimen from the g ra c i l is  muscle. Fibre 
bundles from th is  specimen were suspended in an organ bath (Figure 
2.1) and th e ir  contracture responses to 3% halothane, 2 mM caffe ine, 
1 mM succinylcholine and 80 mM potassium chloride were recorded. 
Muscle s tr ip s  from MHS swine displayed a cha rac te r is t ic
h yp e rc o n tra c t i l i ty  to these agents whereas those from control swine 
did not (Figure 2.2, Table 2 .2).
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3 %  HALOTHANE
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CHLORIDE
t
2 mM CAFFEINE
1 mM SUCCINYLCHOLINE
Figure 2.2 Typical Contracture Responses of Control and Malignant 
Hyperpyrexia Susceptible Muscle to Halothane, Caffeine, 
Succinylcholine and Potassium Chloride.
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Table 2.2 Contracture Responses of Control and Malignant Hyperpyrexia 
Susceptible Swine Skeletal Muscle when exposed to Halothane, 
Caffeine, Succinylcholine and Potassium Chloride.
g tension (mean + S.E.) P value
control MHS
Halothane 3% 0.0284 + 0.006 (93) 0.7567 + 0.045 (187) <0.001
Caffeine 2 mM 0.0359 + 0.01 (90) 0.5317 + 0.036 (149) <0.001
Succinylchol ine 1 mM 0.0701 + 0.021 (79) 0.3724 + 0.029 (125) <0.001
Potassium Chloride 80 mM 0.1264 + 0.06 (80) 1.1513 + 0.087 (119) <0.001
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2.3.2 Contracture Responses Induced by Calmodulin Antagonist Drugs 
The phenothiazine calmodulin antagonists TFP, CPZ, FPZ and PRO, and 
the butyrophenone HPD induced contractures in both control and MHS 
skeletal muscle strips at uM concentrations when added directly to 
the organ bath (Figures 2.3a, 2.4, 2.5, 2.6, 2.7, 2.8). Promethazine 
was the least active of this group of drugs in inducing muscle 
contracture and required an organ bath concentration of at least 200 
j j M before contracture was observed in control or MHS muscle (Figure 
2.7). Contracture was induced by TFP (Figure 2.4), CPZ (Figure 2.5), 
FPZ (Figure 2.6) and HPD (Figue 2.8) at an organ bath concentration 
of 50 jjM in both control and MHS muscle. The size of the 
contractures induced by 50 j j M TFP, 50 pM CPZ and 50 j j M HPD were 
significantly larger in MHS muscle when compared with controls 
(Figure 2.9).
The calmodulin antagonists PEN and PIM did not induce contracture of
either control or MHS muscle str ips. Since these two drugs were the
most insoluble used (Table 2.1), the aqueous organ bath environment
was slightly modified to fac i l i ta te  delivery of these drugs to the
muscle strip. To fac i l i ta te  the solubility of these drugs the Ringer
2 -solution was prepared without SO^  or with up to 5% DMSO. Since 
almost all of the serum concentration of neuroleptic drugs such as 
PEN and PIM is bound to serum proteins (Seeman, 1977), up to 0.5% of 
bovine serum albumin was added to the Ringer solution. None of these 
modifications were successful in inducing PEN or PIM contractures in 
control or MHS muscle strips.
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500 jjM TFP
CONTROL 500 ^jM TFP
t t I
50 100 200
2 min.
t t
200 jjM 6 jjM  
TFP DANTROLENE
I I
200 jjM 6pM
HPD DANTROLENE
Figure 2.3 The Effect of Trifluoperazine on Control and Malignant 
Hyperpyrexia Susceptible Muscle. (a) Typical Dose 
Responses to Trifluoperazine, (b) Partial Reversal of 
Trifluoperazine Contracture compared to Reversal of 
Haloperidol Contracture in Control Muscle.
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F ig u r e  2.4  Dose Response of  C o n t r a c t u r e  Induced by T r i f l u o p e r a z i n e  
in Cont rol  (o) and Mal ignant  Hyperpyrexia  S us c e p t i b l e  
( • )  Muscle.  The r e s u l t s  shown are mean va l ues  + S.E.  
The number of  exper iment s  appears  in b r a c k e t s .
* S i g n i f i c a n l y  g r e a t e r  than c on t ro l  p < 0 . 0 5
** " " " " p < 0 . 0 1
*** " " " " p < 0 . 0 0 5
p < 0 . 0 0 1****
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Figure 2.5 Dose Response of Contracture Induced by Chiorpromazine 
in Control (o) and Malignant Hyperpyrexia Susceptible 
(•)  Muscle. The resu lts  shown are mean values + S.E.
The number of experiments appears in brackets.
* S ig n if ic a n t ly  greater than control p <0 .02
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Figure 2.6 Dose Response of Contracture Induced by Fluphenazine in 
Control (o) and Malignant Hyperpyrexia Susceptible (•) 
Muscle. The resul ts  shown are mean values + S.E. The 
number of experiments appears in brackets. None of the 
MHS values are s ig n i f ic a n t ly  d i f fe ren t  from control
values.
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Figure 2.7 Dose Response of Contracture Induced by Promethazine in 
Control (o) and Malignant Hyperpyrexia Susceptible (•) 
Muscle. The results shov/n are mean values + S.E. The 
number of experiments appears in brackets. None of the 
MHS values are significantly different to control
values.
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Figure 2.8 Dose Response of Contracture Induced by Haloperidol in 
Control (o) and Malignant Hyperpyrexia Susceptible (•) 
Muscle. The results shown are mean values + S.E. The 
number of experiments appears in brackets.
* Significantly greater than control p <0.001
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Figure 2.9 Comparison of Contracture Responses Produced by 
Chlorpromazine, Haloperidol, Trifluoperazine, 
Fluphenazine and Promethazine at a concentration of 50 
jjm in Control and Malignant Hyperpyrexia Susceptible 
Muscle. The results shown are mean values + S.E.
* Significantly greater than control p <0.02
** " " " " p <0.01
*** " " " 1 p <0.001
There are no significant differences between 
contractures produced by chlorpromazine, haloperidol, 
trifluoperazine and fluphenazine in control or 
malignant hyperpyrexia susceptible muscle.
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2.3.3 The Effects of Dantrolene on Contractures Induced by 
Calmodulin Antagonists
Dantrolene sodium was used in the organ bath experiments at a 
concentration of 6  j j M (Denborough, 1980). Dantrolene sodium did not 
completely reverse the contractures caused by calmodulin antagonists 
in control and MHS muscle strips (Figure 2.3b). The degree of 
reversal and inhibition of these contractures was greater with HPD 
than with TFP (Table 2.3). Mean dantrolene sodium reversals of TFP 
contractures in control and MHS muscle were 14.5% and 29%, 
respectively. Mean dantrolene sodium reversals of HPD contractures 
in control and MHS muscle were 78% and 79%, respectively, and were 
significantly different to the TFP results. The mean dantrolene 
sodium inhibition of TFP contractures in control and MHS muscle were 
67% and 42%, respectively, while dantrolene sodium inhibitions of HPD 
contractures in control and MHS muscle were 99% and 97%, 
respectively.
2.3.4 The Effect of Calmodulin Antagonist Drugs on Contractures 
Induced by Halothane, Caffeine, Succinylcholine and Potassium 
Chloride in Control Porcine Muscle
The addition of TFP, HPD and CPZ to the organ bath preparation in j j M 
concentrations caused control muscle to behave in a manner similar to 
MHS muscle. Pretreatment with these drugs for 2 to 5 minutes induced 
control muscle strips to give contracture responses to 3% halothane, 
2 mM caffeine and 1 mM succinylcholine. The responses of control 
muscle to 80 mM potassium chloride were unaffected by calmodulin 
antagonist drugs (Figure 2.10). The calmodulin antagonists PEN and 
PIM did not induce hypercontractility in control muscle.
Table 2 .3  A Comparison of the Extent of Dantrolene Sodium Reversal and
Inhib ition  of Trifluoperazine and Haloperidol Contractures in
Control and Malignant Hyperpyrexia Susceptib le Swine Muscle
Dantrolene Reversal  % 
(Mean + SE)
Dantrolene I n h i b i t i o n  % 
(Mean + SE)
Control  MHS Control MHS
Tr i f l uo pe ra z i ne  14.5 + 3.4  (10) 29 + 6.3 (6) 6 7 + 6  (6) 42 + 14.5 (4)
Haloper idol  78 + 7.4 (5) 79 + 10.5 (3) 99 + 0.7 (3) 97 + 1.2 (3)
P value < 0.001 < 0.01 < 0.01 < 0 . 0 5
1,
0 
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50jjM 3 %  HALOTHANE 
TFP
1 mM SUCCINYL-
CHOLINE
80 mM POTASSIUM
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50 jjM 2 mM CAFFEINE 
TFP
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50jjM 1 mM SUCCINYL- 
TFP CHOLINE
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50 _pM 80 mM POTASSIUM 
TFP CHLORIDE
Figure 2.10 Induction of Hypercon trac t i l i ty  to Halothane, Caffeine and
Succinylchol ine by Tr i f luoperazine in Control Porcine Muscle.
At a concentration of 50 pM, TFP caused control muscle to respond to 
3% halothane with a mean contracture of 0.355g, s ig n if ic a n t ly  larger 
than untreated control tissue but s ig n i f ic a n t ly  less than the mean 
MHS muscle halothane contracture (Table 2 .4 ). Higher concentrations 
of TFP pretreatment induced larger halothane contractures, and at 100 
pM  and 200 pM  TFP these halothane contractures were not s ig n if ic a n t ly  
d i f fe re n t  from the mean MHS muscle halothane contracture (Figure 
2.11). Trifluoperazine-induced caffe ine contractures followed the 
same trend as the TFP-induced halothane contractures. At a 
concentration of 50 jjM TFP a mean caffe ine contracture of 0.125 g was 
recorded, s ig n i f ic a n t ly  larger than untreated control tissue but 
s ig n i f ic a n t ly  less than the mean MHS muscle caffeine contracture 
(Table 2.4). At concentrations of 100 pM  and 200 jjM TFP the caffeine 
contractures were not s ig n i f ic a n t ly  d i f fe re n t  from the mean MHS 
muscle caffe ine contracture (Figure 2.12).
The mean TFP-induced succinylcholine contractures in control muscle 
at TFP concentrations of 50 pM (0.319 g )  and 100 jjM (0.55 g) were not 
s ig n i f ic a n t ly  d i f fe re n t  from the mean MHS muscle succinylcholine 
contracture (Figure 2.13). At a TFP concentration of 200 pM the mean 
succinylcholine contracture in control muscle (0.8 g) was 
s ig n i f ic a n t ly  greater than the mean MHS muscle succinylcholine 
contracture (Figure 2.13).
The mean potassium ch loride contractures in control muscle pretreated 
with 50 pM, 100 pM or 200 pM TFP were not s ig n i f ic a n t ly  d if fe re n t  
from the mean untreated control muscle potassium chloride contracture 
(Table 2.4 and Figure 2.14).
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Figure 2.11 Dose Response of Trifluoperazine-Induced Hypercon­
t r a c t i l i t y  to 3% Halothane in Control Muscle. The
resul t s  shown are mean values _+ S.E. The number of
experiments appears in brackets.
* Signif icant ly greater  than control muscle response 
(without t r i f luoperazine)  p <0 .003  
Q Signif icant ly less than malignant hyperpyrexia 
susceptible muscle response (without 
t r i f luoperazine)  p < 0 . 0 3 .
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Figure 2.12 Dose Response of Trifluoperazine-Induced Hypercon­
t rac t i l i ty  to 2mM Caffeine in Control Muscle. The 
results shown are mean values + S.E. The number of 
experiments appears in brackets.
* Significantly greater than control muscle response 
(without trifluoperazine) p <0.03 
Q Significantly less than malignant hyperpyrexia 
susceptible muscle response (without 
trifluoperazine) p <0.005.
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Figure 2.13 Dose Response of Tri f luoperazine-Induced Hypercon­
t r a c t i l i t y  to ImM Succinylchol ine in Control Muscle. 
The resu lts shown are mean values _+ S.E. The number 
of experiments appears in brackets.
* S ign i f ica n t ly  greater than control muscle response 
(without t r i f luoperaz ine)  p <0.002 
Q S ign i f ica n t ly  greater than malignant hyperpyrexia 
susceptible muscle response (without 
t r i f luoperaz ine)  p <0 .003 .
TE
NS
IO
N
6 6 .
TFP CONC. ( pM )
Figure 2.14 Dose Response of Tr i f luoperazine Effects on 80 mM 
Potassium Chloride-Induced Contracture in Control 
Muscle. The results shown are mean values + S.E. The 
number of experiments appears in brackets.
0 S ig n i f ica n t ly  less than malignant hyperpyrexia 
susceptible muscle response (without 
t r i f luoperaz ine)  p < 0 .0 5  
00 S ign i f ica n t ly  less than malignant hyperpyrexia 
susceptible muscle response (without 
t r i f luoperaz ine)  p <0 .00 1 .
6 7 .
The calmodulin antagonists HPD, CPZ, FPZ and PRO also induced 
h yp e rco n tra c t i l i ty  to halothane, caffe ine and succinylcholine in 
control muscle. S u ff ic ie n t data to permit analysis and comparison 
with TFP was obtained fo r  HPD and CPZ at a pretreatment concentration 
of 50 jjM (Tables 2.5 and 2.6, respective ly ). When the a b i l i t ie s  of 
TFP, HPD and CPZ to induce h yp e rco n tra c t i l i ty  to halothane, caffeine 
and succinylcholine in control muscle were compared, HPD was the most 
potent (Figure 2.15). Haloperidol and CPZ induced s ig n if ic a n t ly  
larger halothane and caffeine contractures when compared with TFP. 
Also, HPD induced s ig n if ic a n t ly  larger succinylcholine contractures 
in control muscle when compared with TFP (Figure 2.15). Contracture 
responses to potassium chloride induced by HPD in control muscle were 
s ig n i f ic a n t ly  greater than those induced by TFP but were not 
s ig n i f ic a n t ly  d i f fe re n t  from the potassium chloride contracture 
responses of untreated control muscle (Figure 2.15).
Dantrolene sodium p a r t ia l ly  reversed (approximately 50%) the 
calmodulin antagonist induced contracture responses to halothane, 
ca ffe ine and succinylcholine in control muscle (Figure 2.16).
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Figure 2.15 Comparison of 50 j j M Haloperidol, 50 j j M Chlorpromazine 
and 50 j j M Trif 1 uoperazine-Induced Hypercontracti1ity 
to Halothane, Caffeine and Succinylcholine in Control 
Muscle. The results shown are mean values + S.E.
* Significantly greater than control muscle response 
(without trifluoperazine) p <0.005 
0 Significantly greater than control + 50 j j M 
trifluoperazine response p < 0 .0 5  
00 Significantly greater than control + 50 pM 
trifluoperazine response p <0.002
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Figure 2.16 Reversal of 100 j j M Tri f luoperazine-Induced 3% 
Halothane, 2 mM Caffeine and 1 mM Succinylchol ine 
Contractures by 6 j j M Dantrolene Sodium in Control
Muscle.
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2.3.5 The Effects of Calmodulin Antagonist Drugs on the
Contractures Induced by Halothane, Caffeine, Succinylcholine 
and Potassium Chloride in Malignant Hyperpyrexia Susceptible 
Porcine Muscle.
The calmodulin antagonists TFP, HPD and CPZ potentiated contractures 
induced by halothane, caffeine and succinylcholine in MHS muscle.
The calmodulin antagonist drugs had no effect on potassium chloride 
induced contractures in MHS muscle. When pretreated with 50 j j M TFP, 
MHS muscle responded to 3% halothane with a mean contracture 
approximately twice as large as the mean halothane contracture in 
untreated MHS muscle (Table 2.4). Greater concentrations of TFP 
(100 j j M and 200 j jM )  did not significantly increase this amount of 
contracture (Figure 2.17). The mean contracture responses of MHS 
muscle pretreated with 50 uM TFP induced by 2mM caffeine and ImM 
succinylcholine were approximately doubled when compared to the mean 
contracture of untreated MHS muscle (Table 2.4 and Figure 2.18). 
Haloperidol and CPZ also potentiated MHS muscle contracture responses 
to halothane, caffeine and succinylcholine (Tables 2.5 and 2.6 and 
Figure 2.18). The potentiating effects of HPD were significantly 
greater than those of TFP in MHS muscle.
Dantrolene sodium reversed the calmodulin antagonist-potentiated 
contracture responses to halothane, caffeine and succinylcholine in 
MHS muscle (Figure 2.19).
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Figure 2.17 Dose Response of Trifluoperazine-Induced Potentiation
of Halothane Contracture in Malignant Hyperpyrexia
Susceptible Muscle. The results shown are mean values
+ S.E. The number of experiments appears in brackets.
* Significantly greater than malignant hyperpyrexia 
susceptible muscle response (without 
trifluoperazine) p <0.05
** Significantly greater than malignant hyperpyrexia 
susceptible muscle response (without 
trifluoperazine) p <  0.005 
*** Significantly greater than malignant hyperpyrexia 
susceptible muscle response (without 
trifluoperazine) p <0.001
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Figure 2.18 Comparison of 50 j j M Haloperidol, 50 j j M Chlorpromazine 
and 50 j j M Trif1uoperazine-Induced Potentiation of 
Halothane, Caffeine and Succinylcholine Contractures 
in Malignant Hyperpyrexia Susceptible Muscle. The 
results shown are mean values _+ S.E.
(Figure 2.18 continued overleaf)
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Figure 2.19 Reversal of 50 j j M Trifluoperazine-Potentiated 3% 
Halothane, 2 mM Caffeine and 1 mM Succinylcholine
Contractures by 6 j j M Dantrolene Sodium in Malignant 
Hyperpyrexia Susceptible Muscle.
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2.4 Discussion
The results obtained in this chapter suggested that the calmodulin
2+antagonist drugs were affecting some aspect of muscle cell Ca
2+metabolism which led to a rise in myoplasmic Ca concentrations in
both control and MHS muscle. The ability of these drugs to increase 
2+the myoplasmic Ca concentration of control muscle induced a MH-like
hypercontractility to halothane, caffeine and succinylcholine in this
tissue. This observation was consistent with the view that MHS
muscle hypercontractility was caused by an abnormally high myoplasmic 
2+Ca concentration. Also, since the calmodulin antagonist drugs were 
able to affect the contractile characteristics of both control and 
MHS muscle, calmodulin did not appear to play a unique role in MHS 
muscle hypercontracti1i t y .
The hypothesis that the calmodulin antagonist drugs induced
alterations in the contractile characteristics of skeletal muscle in
2+vitro by inducing an increase in the myoplasmic Ca concentration 
was consistent with a number of observations. The drugs TFP, HPD, 
CPZ, FPZ and PRO induced j_n vitro contractures in control and MHS 
muscle. The drug which was studied in the greatest detail was TFP. 
The contractures induced by TFP in MHS muscle at concentrations of 50 
j j M ,  100 j j M , 200 j j M and 500 j j M were significantly greater than those
induced in control muscle at these concentrations. This difference
O I
might be explained by the abnormally high myoplasmic Ca 
concentration thought to be present in resting MHS muscle. 
Trifluoperazine, HPD and CPZ also induced hypercontractility to 
halothane, caffeine and succinylcholine in control muscle and 
potentiated the hypercontractility of MHS muscle to these agents.
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The inability of the calmodulin antagonists to induce potassium
chloride contracture in control muscle may be due to an electrical
stabilization of the sarcolemma by these drugs. Chlorpromazine and
other hydrophobic drugs have been shown to reduce the excitability of
excitable membranes (Langslet, 1970; Seeman, 1972). Electrical
stabilization of the control muscle sarcolemma may prevent
depolarization by 80 mM potassium chloride and therefore prevent
potassium chloride contracture. The inability of the calmodulin
antagonist drugs to potentiate potassium chloride contractures in MHS
muscle appears to be more complex. Let us assume that the MHS
sarcolemma was stabilized to the same degree as the control
sarcolemma by calmodulin antagonist drugs, and that this
stabilization was not absolute. In control muscle, the residual
depolarization caused by potassium chloride in the presence of
calmodulin antagonist drugs was insufficient to induce contracture.
? +In MHS muscle, where the abnormally high myoplasmic Ca 
concentration had been further increased by the action of the 
calmodulin antagonist drug, the residual depolarization might induce 
a contracture which was not significantly different to an untreated 
MHS muscle potassium chloride contracture. Alternatively, the 
ability of the MHS sarcolemma to be depolarized in the presence of 
electrical stabilization by calmodulin antagonist drugs may be due to 
an abnormality of the MHS sarcolemma such as that described by 
Gallant, Godt and Gronert (1979). These authors observed that
halothane depolarized the sarcolemma of MHS muscle but not control 
muscle. The observations made in the present study may suggest a 
basic difference in the mode of action of potassium chloride in 
skeletal muscle when compared to halothane, caffeine and 
succinylcholine.
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The most potent calmodulin antagonist drugs tested in the in vitro 
muscle strip experiments (PEN and PIM) failed to induce the effects 
observed with other antagonist drugs. The failure of PEN and PIM to 
induce effects in skeletal muscle strips may be due to their 
insolubility in the aqueous organ bath environment (octanol/water 
partition coefficients 40,000,000 and 2,000,000, respectively).
The mechanism by which calmodulin antagonist drugs affect myoplasmic 
2+Ca metabolism may include a number of sites of action. Of the
known calmodulin-dependent functions in skeletal muscle (Chapter
1.11.3), two may have contributed to this effect. Firstly, the
calmodulin-dependent phosphorylation of one of the three myosin light
chains by myosin light chain kinase (MLCK) (Mayr and Heilmeyer, 1983)
may be involved. Although no definition of MLCK function has been
described, cycles of phosphorylation and dephosphorylation of this
myosin light chain have been observed in response to contraction and
relaxation (Manning and Stull, 1979). I t  has been proposed by Crow
and Kushnerick (1982) that light chain phosphorylation may regulate
the rate of cross-bridge turnover. If this proposal was correct,
however, inhibition of calmodulin function by calmodulin antagonist
drugs would be expected to favour muscle relaxation, not contraction.
Secondly, a calmodulin-dependent protein phosphorylation system of
the SR membrane has been proposed to be involved in the regulation of
the release of Ca^+ from the SR (Campbell and MacLennan, 1982; Chiesi
and Carafoli, 1982, 1983). Although the function of these protein
phosphorylations has not been elucidated, inhibition of this
calmodulin dependent function by calmodulin antagonist drugs might
2 +lead to a disruption of the regulation of Ca release from the SR
2+resulting in a rise in the myoplasmic Ca concentration.
80 .
The published inh ib ito ry  potencies and octanol/water partition  
coeffic ients of the calmodulin antagonist drugs used in the present 
study (Table 2.1) did not always correlate with the ir pharmacological 
potencies in v itro  (Figure 2.9). Promethazine was the least potent 
calmodulin antagonist and the least hydrophobic drug tested, and i t  
did not induce contracture in control or MHS muscle un til high 
concentrations were reached. Trifluoperazine, however, was 
approximately six times more potent an inh ib ito r of calmodulin 
function than HPD, yet HPD was at least as potent, i f  not more 
potent, in producing contracture in control and MHS muscle (Figure 
2.9), in inducing hypercontractility in control muscle (Figure 2.15) 
and in potentiating hypercontractility in MHS muscle (Figure 2.18). 
These observations suggest that a mode of action other than 
calmodulin inh ib ition  may be important in the effects of calmodulin 
antagonist drugs on skeletal muscle in v it ro .
Calmodulin antagonist drugs have been shown to bind to troponin C
(Levin and Weiss, 1978). At concentrations greater than 10 j j M TFP,
the extent of TFP binding to calmodulin and troponin C was sim ilar.
2+Since troponin C confers Ca sens itiv ity  on the contractile elements
O x
in muscle, an increase in the sens itiv ity  of troponin C to Ca , or
an activation of troponin C in the absence of Ca , brought about by
the binding of a calmodulin antagonist drug might produce effects
2+sim ilar to those of an increased myoplasmic Ca concentration.
Takagi (1981) found that in skinned muscle fibres of the guinea pig
the addition of CPZ made the contractile system more sensitive to 
2+Ca . Such an effect of calmodulin antagonist drugs may have 
contributed to th e ir effects in control and MHS muscle in the present 
study.
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Due to the high lipid solubility of the calmodulin antagonist drugs, 
effects on the sarcolemma and the SR would seem likely at the 
concentrations used in the organ bath. Chiorpromazine has been found
pi
to inhibit the active Ca uptake by isolated SR (Balzer, Makinose
2+and Hasselbach, 1968) and the influx and efflux of Ca through the
sarcolemma (Balzer and Hellenbrecht, 1969). Andersson (1972) and
Takagi (1981) both concluded that the major contractile effects
produced by CPZ in skeletal muscle fibres were mediated by i ts  action
2+upon the SR, releasing Ca .
Contractures produced by TFP and HPD in control and MHS muscle 
differed in the degree to which they were reversed by dantrolene 
sodium (Table 2.3). Haloperidol contractures were reversed by 
dantrolene sodium by approximately 78% whereas TFP contractures were 
reversed by dantrolene sodium by approximately 20%. This difference 
might be due to HPD being more active than TFP at a dantrolene sodium 
sensitive si te .  I t  might also be explained if  these two drugs both 
affected the same dantrolene sodium-sensitive site but TFP, being 
more hydrophobic than HPD, was harder for dantrolene sodium to 
displace (Table 2.1). The dantrolene sodium-sensitive site in 
skeletal muscle is thought to be excitation-contraction coupling (E-C
coupling) (Ellis and Bryant, 1972). Dantrolene sodium does not
2+ 2 + stimulate the Ca -dependent ATPase of the SR or affect Ca exchange
or efflux rates of the SR (White, Collins and Denborough, 1983).
2.5 Summary
The effects of calmodulin antagonist drugs on control and MHS muscle 
in vitro did not reveal any unique or specific role for calmodulin in
the hypercontractility of MHS muscle. The calmodulin antagonist
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drugs induced contracture in both control and MHS muscle s tr ip s ,
induced h y p e rco n tra c t i l i ty  to halothane, caffe ine and succinylcholine
in control muscle, and potentiated hypercontracti1i t y  to halothane,
ca ffe ine  and succinylcholine in MHS muscle. These e ffec ts  were
probably due to a r ise  in the concentration of myoplasmic Ca caused
by the calmodulin antagonist drugs in both control and MHS muscle.
2+This increase in  myoplasmic Ca concentration may have been due to
2+the calmodulin antagonist drugs releasing Ca from the SR by acting 
on the calmodulin-dependent protein kinase system of the SR or by 
calmodulin-independent, non-specific in te ractions with the SR 
membrane. Other mechanisms by which calmodulin antagonist drugs 
might e f fe c t  the co n tra c t i le  cha rac te r is t ics  of control and MHS
muscle include binding to troponin C thereby causing an increase in
2+the s e n s i t iv i t y  of the co n tra c t i le  elements to Ca , and by acting on 
the E-C coupling mechanism.
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CHAPTER 3 CALMODULIN IN  PORCINE MALIGNANT HYPERPYREXIA
3.1 Introduction
The in trace llu la r calcium binding protein calmodulin plays a major
2+role in mediating the effects of changes in Ca levels in many types
2 +of cells (Chapter 1.4). The Ca -calmodulin complex is  able to bind 
to its  effector proteins and bring about a change in the ir 
a c tiv itie s . One of the major roles played by calmodulin in some
cells  (fo r example, the erythrocyte) is  to regulate the in trace llu la r
2+ 2+ levels of Ca . That is , i t  is  able to regulate Ca transport
across some membranes. Since calmodulin plays these multiple roles 
2 +in ce llu la r Ca regulation and mediation, and since the behaviour of 
skeletal muscle from MHS individuals and swine in v itro  suggests an 
abnormality in some aspect of Ca regulation (Denborough, 1980), i t  
was decided to investigate the role of calmodulin in MH.
The f i r s t  step in th is  investigation involved the pharmacological 
effects of calmodulin antagonist drugs on porcine skeletal muscle 
strips j_n v it ro . This work is  described in the previous chapter. 
B rie fly , these drugs caused control swine skeletal muscle to behave 
in a sim ilar manner to muscle from MHS swine, that is , they induced a 
hypercontractility to halothane, caffeine and succinylcholine. 
Dantrolene sodium p a rtia lly  reversed the contractures which were 
produced. The hypercontractility of MHS muscle was potentiated by 
the calmodulin antagonist drugs.
Because of the effects induced by calmodulin antagonists in skeletal 
muscle s trips, the pharmacological work was extended to the isolation
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of calmodulin from control and MHS porcine brain. These preparations 
were then compared both fu n c t io n a lly  and physica lly to determine i f  
they d if fe red  in any way.
3.2 Materials and Methods
3.2.1 Drugs and Reagents
The fo llow ing g i f t s  of drugs are g ra te fu l ly  acknowledged: TFP from
Smith, Kline and French Laboratories (A us tra l ia ) ,  FPZ from E.R. 
Squibb and Sons, and HPD from Searle Laboratories.
A ll other reagents were of analytica l grade.
3.2.2 Iso la t ion  of Calmodulin from Control and Malignant 
Hyperpyrexia Susceptible Porcine Brain
Calmodulin preparations were iso la ted from both control and MHS 
porcine brains essentia lly  by the method of Kakiuchi, Sobue, 
Yamazaki, Kambayashi, Sakon and Kosaki (1981). The brains were 
removed immediately post-mortem, placed in to  l iq u id  nitrogen and 
stored at -70°C u n t i l  used.
A ll procedures were carried out between 0° and 4°C. Frozen brain 
t issue (70 - 110 g) was homogenized in approximately 4 volumes of 4% 
tr ic h lo ro -a c e t ic  acid (TCA) and then s t i r re d  slowly in the cold fo r  
20 minutes. This mixture was centrifuged at 20,000xg fo r  30 minutes 
and the p e l le t  homogenized in 250 ml of 20 mM Tris (hydroxymethyl) 
aminomethane (T r is ;  pH 7 .5), 5 mM ethylenediaminotetra-acetic acid
(EDTA), 0.1 mM phenylmethylsulfonylfluoride (PMSF), 0.05 jjg/ml 
pepstatin A and 2 jjg/ml antipain (Buffer A). A fte r adjusting the pH
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of th is  homogenate to 7.5, i t  was centrifuged at 100,000xg for 2
hours. The pe l le t s  were washed with the same buffer and the 
supernatants were combined. These supernatants were then applied to 
a diethyl ami noethyl-cel lulose (DEAE-cellulose) column (2.5 x 32 cm) 
equil ibrated with 20 mM Tris (pH 7.5),  5 mM 2-mercaptoethanol and
0.1 mM ethyleneglycolte tra-acetic  acid (EGTA). The column was eluted 
with th is  buffer plus 0.145 M and 0.3 M (NH^/^SO^ in a stepwise
manner. Fractions of 8 ml were collected.  Those fractions
containing calmodulin ac t iv i ty  were combined and diluted with an
equal volume of 20 mM Tris (pH 7.5),  5 mM 2-mercaptoethanol and
0.5 mM CaC 12 and applied to an a f f in i ty  column of FPZ coupled to
Sepharose 6B which had been equilibrated with 20 mM Tris (pH 7.5), 
5 mM 2-mercaptoethanol, 500 mM NaCl and 0.2 mM CaCl? . The column was 
eluted with th is  buffer ,  then with the same buffer except that  the 
CaCl^ was replaced by 2 mM EGTA. Fractions of 4 ml were collected,  
and those containing calmodulin ac t iv i ty  were combined, dialysed
against 10 mM Tris (pH 7.0),  and lyophilized.
3.2.3 The Assay of Calmodulin Activity
Calmodulin ac t iv i ty  was measured by the method of Teo, Wang and Wang 
(1973) with minor modifications. The sample for assay was mixed with 
0.016 units of calmodulin-deficient cyclic-AMP phosphodiesterase 
(Sigma Chemical Company, product number P-0520) and 0.2 units of 5' 
nucleotidase (Sigma Chemical Company, product number N-4005) in 
0.5 ml and equil ibrated at 37°C. The reaction was in i t i a ted  by the 
addition of 0.5 ml of 72 mM Tris (pH 7.5) , 72 mM imidazole, 36 mM Mg
aceta te ,  1.8 mM cyclic-AMP and 1 0 0  j j M CaCl^. The reaction was
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terminated after  30 minutes by the addition of 4 ml of inorganic 
phosphate reagent.
The calmodulin inhibit ion studies were carried out as above with a 
standard amount of calmodulin (100 ng).
3.2 .4 The Assay of Porcine Skeletal Muscle Cyclic Adenosine 
31,5 1-monophosphate
Samples of g rac i l i s  muscle were obtained by biopsy under 
pentothal/N^O anaesthesia, immediately frozen in liquid nitrogen and 
stored at -70°C until  used. Approximately 0.5 g (wet weight) of 
muscle t issue  was homogenized in 7% TCA using a Polytron homogenizer. 
An aliquot of th is  homogenate was taken for protein determination. 
The remainder was centrifuged at 3,000xg for 15 minutes and then the 
supernatant was extracted 3 times with 2-3 volumes of water-saturated 
e ther to remove the TCA. The extracted supernatant was then bubbled 
with nitrogen for 5-10 minutes. An aliquot was then taken for 
analysis by a Radiochemical Centre, Amersham (Buckinghamshire, 
England) Cyclic AMP assay kit  (code TRK. 432).
3.2.5 Ultraviole t  Absorption Spectrum of Calmodulin 
Ultraviole t  absorption spectra of calmodulin preparations were 
performed using a Beckman DU-8 spectrophotometer and wavelength scan 
module. The wavelengths examined were 240 - 320 nm, and the protein 
concentration was 0.5 mg/ml in 0.1 M imidazole and 1 mM EDTA (pH 
7.0).
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3.2.6 Polyacrylamide Gel Electrophoresis of Proteins 
Polyacrylamide gel electrophoresis (PAGE) was performed according to 
the method of Laemmli (1970), using 10 - 20% acrylamide gradient slab 
gels with a 4.5% acrylamide stacking gel. Gels were run at 40 ma/gel 
and stained with Coomassie blue.
3.2.7 Inorganic Phosphate Determinations
Inorganic phosphate was determined by the method of Heinonen and 
Lahti (1981).
3.2.8 Protein Determinations
Protein concentrations were determined by a modification of the Lowry 
method (Peterson, 1977).
3.3 Results
3.3.1 Iso la t ion  of Calmodulin from Control and Malignant
Hyperpyrexia Susceptible Porcine Brain 
In order to compare the physical and functional cha rac te r is t ics  of 
calmodulin from control and MHS swine, preparations of th is  protein 
were extracted from porcine brains. Although we were interested in 
calmodulin function in skeletal muscle, brain preparations were used 
since calmodulin lacks tissue s p e c i f ic i ty  (Kakiuchi, Sobue, Yamazaki, 
Kambayashi, Sakon and Kosaki, 1981) and brain is  the r iches t source
of calmodulin (Smoake, Song and Cheung, 1974). The iso la t io n  
procedure u t i l iz e d  a TCA extraction of whole brain followed by 
DEAE-cellulose chromatography. A subsequent a f f in i t y  chromatography 
step u t i l iz e d  one of the phenothiazines known to bind to calmodulin
o .
in a Ca -dependent manner (fluphenazine) coupled to Sepharose 6B
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(Figures 3.1, 3.2 and 3.3). The calmodulin containing eluate from
the DEAE-cellulose column was applied to the phenothiazine a ff in i ty
2 +column in the presence of Ca under conditions where calmodulin 
would bind to the column. Elution of the bound calmodulin was 
carried out in the presence of EGTA. Extraction of control and MHS
brains gave similar  elution prof i les  and protein compositions.
3.3.2 Sodium Dodecyl Sulphate Electrophoretic Comparison of 
Calmodulins Isolated from Control and Malignant Hyperpyrexia 
Susceptible Porcine Brain
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) 
of calmodulins isolated from control and MHS porcine brain showed no 
difference between these two proteins (Figure 3.4). The calmodulin 
band, running at approximately 17,000 MW, is accompanied by a number 
of contaminants of both higher and lower MW. Commercially available 
porcine brain calmodulin (Sigma Chemical Company), isolated using a 
method similar to the present study, also contains contaminants in 
the 19,000 to 21,000 MW range. The low MW contaminant (approximately 
14,000 MW) are not present in the commercial preparation. They may 
be breakdown products of calmodulin accumulated a f te r  extended 
storage.
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Figure 3.1 The Elution Profile of Protein and Calmodulin Activity 
from the DEAE-Cellulose Column used in the Isolation 
of Calmodulin from Malignant Hyperpyrexia Susceptible 
Porcine Brain.
I . Sample applied.
II.  Elution buffer plus 0.145 M (NH^ )  ^ SO^ .
III .  Elution buffer plus 0.3 M (NH^ )  ^ SO^
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Figure 3.2 E lu t ion  P ro f i le  o f  Protein and Calmodulin A c t i v i t y  
from the A f f i n i t y  Column used in  the Is o la t io n  of 
Calmodulin from Malignant Hyperpyrexia Suscept ible 
Porcine Brain.
I .  Sample appl ied.
I I . E lu t ion  b u f fe r .
I I I .  E lu t ion bu f fe r  plus 2 mM EGTA
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Figure 3.3 Polyacrylamide Gel Pattern of Various Fractions 
obtained during the Isolation of Calmodulin from 
Malignant Hyperpyrexia Susceptible Porcine Brain.
A. TCA homogenate
B. Buffer A extract
C. 0.3M (NH^SO^ DEAE-cel lulose column eluate
D. 2mM EGTA affinity column eluate.
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Figure 3.4 Comparison of Polyacrylamide Gel Patterns of
Calmodulin Isolated from Control and Malignant
Hyperpyrexia Susceptible Porcine Brain.
A. Control
B. MHS
C. Commercially avai lable porcine brain 
calmodulin (Sigma Chemical Company)
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3.3.3 Comparison of the Ultraviolet Absorption Spectra of 
Calmodulin Isolated from Control and Malignant Hyperpyrexia 
Susceptible Porcine Brain
Calmodulin exhibits a UV absorption spectrum similar to that of 
troponin C with a major peak at approximately 280 nm and a trough at 
approximately 250 nm (Figure 3.5). The multiple shoulders between 
250 and 280 nm are characteristic of the fine structure of the 
absorption band of phenylalanine (Klee, 1977; Waterson, Harrelson, 
Keller, Sharief and Vanaman, 1976). The UV absorption spectra of 
calmodulin prepared from control and MHS porcine brain were virtually 
identical.
3.3.4 Functional Studies of Calmodulin Isolated from Control and 
Malignant Hyperpyrexia Susceptible Porcine Brain
3.3.4.1 Activation of Phosphodiesterase
The most commonly used assay of the activity of calmodulin is i ts  
ability to activate a calmodulin-dependent 3 ' :5 1-cyclic nucleotide 
phosphodiesterase (Teo, Wang and Wang, 1973). This enzyme degrades 
cyclic-AMP to 5'-AMP, which can be further degraded by
5 ' -nucleotidase to release inorganic phosphate (P^). The amount of
P^  released is measured photometrically.
The abili ties of calmodulins isolated from control and MHS porcine 
brain to activate phosphodiesterase were similar (Figure 3.6). They 
were also similar to published activities for calmodulin isolated 
from bovine brain (Lin, Liu and Cheung, 1974; Sharma and Wang, 1979). 
Fifty per cent activation of 0.016 units of phosphodiesterase was 
achieved using 30-40 ng of calmodulin.
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WAVELENGTH ( n m )
Figure 3.5 Comparison of the U ltra-v io let Absorbance Spectra of 
Calmodulin Isolated from Control and Malignant 
Hyperpyrexia Susceptible Porcine Brain.
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Figure 3.6
PROTEIN CONC. ( n g )
The Activation o f Phosphodiesterase by Control and 
Malignant Hyperpyrexia Susceptible Porcine Brain 
Calmodulin. 
o Control
•  MHS
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3.3.4.2 Inhibition of Calmodulin-Activated Phosphodiesterase by 
Calmodulin Antagonists
Calmodulins isolated from control and MHS porcine brain were also 
compared by investigating the pattern of inhibition of
phosphodiesterase, activated by these calmodulins, by calmodulin 
antagonists. Trifluoperazine and HPD were chosen for these 
investigations because of their different inhibitory potencies (Table 
2.1) and the characteri sties of their _in_ vitro skeletal muscle 
pharmacology. Both TFP and HPD were able to produce contracture in 
control and MHS muscle, but HPD contractures were reversed by 
dantrolene sodium to a significantly greater extent than TFP 
contractures (Table 2.3). The effect of dantrolene sodium on the 
inhibition of calmodulin-activated phosphodiesterase activity by TFP 
and HPD was investigated because dantrolene sodium reversed
contractures induced ijn vitro by calmodulin antagonists and this 
reversal might be due to a direct effect of dantrolene sodium on 
calmodulin.
Phosphodiesterase activities activated by calmodulins isolated from 
control and MHS porcine brain were inhibited by TFP to a similar 
degree (Figures 3.7 and 3.8). An I^g concentration for TFP of 
approximately 1 2  j j M was observed for b o t h  control and MHS 
calmodulin-activated activities.  Dantrolene sodium had no effect on 
the inhibition by TFP of the phosphodiesterase activities activated 
by control or MHS calmodulin.
Phosphodiesterase activities activated by calmodulins isolated from 
control and MHS porcine brains were inhibited by HPD to a similar
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Figure 3.7
TFP CONC. ( j j M )
The Inhibition by Trifluoperazine of Phosphodiesterase 
Activity Activated by Control Porcine Brain Calmodulin 
o TFP
□ TFP plus 20 jjM dantrolene sodium
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Figure 3.8
TFP CONC. ( JjM )
The In h ib i t io n  by Trif luoperazine of Phosphodiesterase 
A c t iv i ty  Activated by Malignant Hyperpyrexia 
Susceptible Porcine Brain Calmodulin 
t TFP
■ TFP plus 20 jjM dantrolene sodium
• ■i
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degree (Figures 3.9 and 3.10). An 1 ^  concentration for HPD of 
approximately 500 j j M was observed for both control and MHS 
calmodulin-activated activities .  Dantrolene sodium had no effect on 
the inhibition by HPD of the phosphodiesterase activities activated 
by control or MHS calmodulin.
(The results of the phosphodiesterase activation and drug inhibition 
studies of calmodulin were confirmed using another control and MHS 
preparation.)
3.3.5 The Concentrations of Cyclic-Adenosine Monophosphate in 
Control and Malignant Hyperpyrexia Susceptible Porcine 
Skeletal Muscle
Calmodulin has been shown to regulate the activities of the enzymes 
phosphodiesterase and adenyl cyclase in a number of tissues (Cheung, 
Lynch and Wallace, 1978; Smoake, Song and Cheung, 1974). Thus, the 
activity and levels of calmodulin in a specific tissue may regulate 
the concentration of cyclic-AMP in that tissue. Because of this ,  the 
concentration of cyclic-AMP in control and MHS skeletal muscle was 
investigated as a possible indicator of calmodulin function in these 
t issues .
Biopsy specimens from the gracilis muscle of control and MHS swine 
were analysed for their cyclic-AMP concentration using a commercially 
available cyclic-AMP test kit.  Control muscle was found to contain 
213 + 67 pmoles of cyclic-AMP per gram of tissue and 9.6 + 4.8 pmoles 
of cyclic-AMP per mg of protein (mean + S.D.). Muscle from MHS swine
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Figure 3.9
HPD CONC.  ( JJM )
The Inhibition by Haloperidol of Phosphodiesterase 
Activity Activated by Control Porcine Brain Calmodulin 
o HPD
□ HPD plus 20 uM dantrolene sodium
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Figure 3.10 The In h ib it io n  by Haloperidol of Phosphodiesterase 
A c t iv i ty  Activated by Malignant Hyperpyrexia 
Susceptible Porcine Brain Calmodulin 
t  HPD
■ HPD plus 20 jjM dantrolene sodium
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was found to contain 225 + 60 pmoles of cyclic-AMP per gram of t issue
and 7.2 ^ 2 . 5  pmoles of cyclic-AMP per mg of protein (mean + S.D.)
(Table 3.1) . These concentrations did not d i f f e r  s ignif icant ly  
between control and MHS muscle.
3.4 Discussion
The resu l ts  obtained in th is  chapter showed that  the calmodulins
isolated from control and MHS porcine brain did not d i f fe r  in the i r
physical or functional charac te r i s t ie s .  Because of the reported lack
of t is sue  spec i f ic i ty  of calmodulin (Wang and Waisman, 1979;
Kakiuchi, Sobue, Yamazaki, Kambayashi, Sakon and Kosaki, 1981) the
isolated brain calmodulin was assumed to be identical  to the
calmodulin present in the skeletal muscle of control and MHS swine.
The procedure for the isolation of calmodulin used in the present
investigation employed an a ff in i ty  chromatography step for the final
puri f icat ion  (Kakiuchi, Sobue, Yamazaki, Kambayashi, Sakon and
Kosaki, 1981). After the porcine brain t issue  had been homogenized,
extracted, and the extract  subjected to ion exchange chromatography,
the fract ions containing calmodulin ac t iv i ty  were applied to a
Sepharose 6B-coupled fluphenazine a f f in i ty  column. The i n i t i a l
2+conditions of the a f f in i ty  column, that  i s ,  the presence of Ca ,
allowed calmodulin to bind to the immobilized fluphenazine.
2+Replacement of the Ca present in the elution buffer with EGTA 
allowed the calmodulin to be eluted from the a f f in i ty  column. The
calmodulins from both control and MHS porcine brain behaved 
ident ica l ly  throughout the isola t ion procedure.
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Table 3.
C o n t r o l
The Concentration of Cyclic-Adenosine Monophosphate in 
Control and Malignant Hyperpyrexia Susceptible Porcine 
Skeletal Muscle.
C y c l i c - A M P  c o n c e n t r a t i o n  ( mean  + S . D . )  n
p m o l e s / g  t i s s u e  p m o l e s / m g  p r o t e i n
213 + 67 9.6 + 4.8 10
MHS 225 + 60 7.2 + 2.5 21
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The polyacrylamide gel patterns of the calmodulin preparations
isolated from control and MHS porcine brain did not differ. This
observation is consistent with a report by Lorkin and Lehmann
(1983b). These authors, using 2 dimensional electrophoresis, found
no differences between calmodulins isolated from control and MHS
porcine erythrocytes. In the present study, the MW of the control
and MHS calmodulins were identical to the MW of a commercially
available porcine brain calmodulin, and comparable to the MW of
calmodulins isolated from various sources (approximately 17,000 MW)
(Cheung, 1980; Scharff, 1981). Three protein contaminants in the MW
range 19,000 to 21,000 are present in the control, MHS and commercial
calmodulin preparations. Since the commercial calmodulin preparation
was isolated by an affinity chromatography procedure similar to the
one employed in the present investigation, these contaminants appear
to be brain proteins which, like calmodulin, had the ability to bind
2+to the affinity column in a Ca -dependent manner. The low MW 
contaminants (approximately 14,000 MW) which were present in the 
control and MHS calmodulin preparations, but not the commercial 
calmodulin preparation, may have been breakdown products of 
calmodulin formed after prolonged storage.
The UV absorption spectra (240 nm to 320 nm) of calmodulins isolated 
from control and MHS porcine brain were virtually identical. 
Calmodulin had a distinctive UV absorption pattern because of i ts  
high ratio of phenylalanine (eight residues) to tyrosine (two 
residues) (Cheung, 1980). This type of UV absorbance spectrum was 
similar to that of another Ca^+-binding protein, troponin C, which
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shares significant sequence homology with calmodulin (Watterson, 
Harrelson, Keller, Sharief and Vanaman, 1976).
Functional studies of calmodulins isolated from control and MHS 
porcine brain did not detect any differences in the function of these 
proteins. The assay of calmodulin function used in the present 
investigation was the activation of a ca.lmodulin-deficient 
phosphodiesterase from bovine heart. The activation curves of 
control and MHS calmodulin preparations were similar with 50% 
activation of phosphodiesterase requiring 30 - 40 ng of calmodulin. 
This 50% activation figure was comparable to that obtained for bovine 
brain calmodulin (Lin, Liu and Cheung, 1974; Sharma and Wang, 1979) 
and confirmed an earl ier study of control and MHS porcine brain 
calmodulin activation of phosphodiesterase (Marjanen, Collins and 
Denborough, 1984). The ability of calmodulin antagonist drugs to 
inhibit calmodulin-activated phosphodiesterase activity was also used 
to compare the control and MHS calmodulin preparations. The drugs 
TFP and HPD inhibited calmodulin-activated phosphodiesterase activity 
activated by control and MHS calmodulins, and the characteristics and 
extent of this inhibition did not differ between these calmodulins. 
These results using TFP were consistent with an earlier report using 
control and MHS porcine brain calmodulin (Marjanen, Collins and 
Denborough, 1984). The concentration for TFP inhibition of 
phosphodiesterase activity activated by control and MHS brain 
calmodulin of 12 j j M obtained in the present study is comparable to a 
published TFP I^q value of 10 j j M using bovine brain calmodulin (Levin 
and Weiss, 1976). The I^q concentration for HPD inhibition of 
phosphodiesterase activity activated by control and MHS brain
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calmodulin of approximately 500 _pM was much higher than a published 
HPD Igg value of 60 jjM (Levin and Weiss, 1979). Levin and Weiss 
(1979) used calmodulin from bovine bra in, a phosphodiesterase from 
ra t  brain and a lu c i fe r in - lu c ife ra s e  method to determine
phosphodiesterase a c t iv i ty  in th e ir  HPD I ^ q study, but the reason fo r  
th is  HPD IgQ discrepancy is  not apparent.
The e ffe c t of the skeletal muscle relaxant dantrolene sodium on the 
in h ib i t io n  of calmodulin function by calmodulin antagonist drugs was 
investigated because of the a b i l i t y  of dantrolene sodium to p a r t ia l ly  
reverse contractures induced by calmodulin antagonist drugs in 
control and MHS skeletal muscle in v i t r o  (Chapter 2 .3 .3). However 
dantrolene sodium had no e ffe c t on the in h ib i t io n  of
calmodulin-activated phosphodiesterase a c t iv i ty  by TFP or HPD, using 
e ith e r control or MHS porcine brain calmodulin. This observation 
suggested the reversal of calmodulin antagonist drug-induced 
contractures by dantrolene sodium was not due to a d ire c t in te raction  
of dantrolene sodium and calmodulin. I t  also implied tha t calmodulin 
antagonist drugs acted in v i t ro  at a s i te  other than calmodulin which 
was sensitive to dantrolene sodium. Dantrolene sodium is  thought to 
act on E-C coupling in skeletal muscle (E l l is  and Bryant, 1972) and, 
therefore , the calmodulin antagonist drugs may have acted in ,  part, 
on E-C coupling to induce in v i t ro  contractures in control and MHS 
skeletal muscle.
Since calmodulin has been shown to regulate the a c t iv i t ie s  of the 
enzymes phosphodiesterase and adenyl cyclase in  a number of tissues 
(Smoake, Song and Cheung, 1974; Cheung, Lynch and Wallace, 1978), the
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concentration o f cyclic-AMP in control and MHS porcine skeletal 
muscle was investigated as a possible in d ire c t ind ica to r of 
calmodulin function in these tissues. This ind ica to r was based on 
two assumptions. F i r s t l y ,  that there were calmodulin-dependent forms 
of phosphodiesterase and adenyl cyclase present in porcine skeletal
muscle, and secondly, that the proportion of these
calmodulin-dependent forms were high enough compared to
calmodulin-independent forms to influence cyclic-AMP leve ls . An
increase in the content of cyclic-AMP has been reported fo r  human MHS 
muscle when compared to control muscle (W illner, Cerri and Wood, 
1981). An increased concentration of cyclic-AMP has also been 
reported in MHS swine longissimus muscle at three minutes post mortem 
(Ono, Topel and Althen, 1976), but no changes in the a c t iv i t ie s  of 
phosphodiesterase or adenyl cyclase were detected (Ono, Topel and 
Althen, 1977). In the present inves t iga t io n , no s ig n if ic a n t 
d iffe rence was found between the concentrations of cyclic-AMP in 
control and MHS g ra c i l is  muscle. Taking in to  account the assumptions 
mentioned above, th is  observation implied that there was no 
detectable d ifference in the function of calmodulin in control and 
MHS skeletal muscle.
3.5 Summary
The e ffec ts  of the calmodulin antagonist drugs on the co n tra c t i le  
cha rac te r is t ics  of control and MHS porcine skeletal muscle _i_n v i t ro  
prompted a biochemical investigation of the Ca -regulatory protein 
calmodulin iso la ted from control and MHS porcine brain. The physical 
properties of these two proteins, tha t is  th e ir  behaviour during the 
is o la t io n  procedure, th e ir  cha rac te r is t ics  on polyacrylamide gel
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electrophoresis and th e i r  UV absorbance spectra, did not d i f f e r .  The 
functional properties of calmodulins isolated from control and MHS 
brain,  that is  th e i r  act ivat ion of the enzyme phosphodiesterase and 
the character is t ics  of the in h ib i t io n  of th is  a c t i v i t y  by calmodulin 
antagonist drugs, were s im i la r .  Also, the concentration of 
cyclic-AMP in the g r a c i l i s  muscle of control and MHS swine, which was 
investigated as a possible ind icator  of calmodulin function in these 
t issues, was not s ig n i f ic a n t ly  d i f fe re n t .  These observations
suggested that MH in swine is  not due to an abnormality in 
calmodulin.
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CHAPTER 4 THE EFFECTS OF CALMODULIN ANTAGONISTS ON ISOLATED 
SARCOPLASMIC RETICULUM FROM CONTROL AND MALIGNANT 
HYPERPYREXIA SUSCEPTIBLE SWINE
4.1 Introduction
In the preceding chapters the e ffec ts  of calmodulin antagonists on 
skeleta l muscle from control and MHS swine have been described. In 
v i t r o  pharmacological observations (Chapter 2) showed that these 
drugs caused control swine skeletal muscle to behave in a s im ila r 
manner to muscle from MHS swine, that is ,  they induced 
h yp e rco n tra c t i l i ty  to halothane, caffe ine and succinylcholine. 
Dantrolene sodium p a r t ia l ly  reversed these contractures. In 
add it ion , the h yp e rco n tra c t i l i ty  of MHS muscle was potentiated by 
calmodulin antagonists. Calmodulins iso lated from control and MHS 
porcine brain were ind is tingu ishable  (Chapter 3). Trifluoperazine 
was shown to in h ib i t  both control and MHS brain calmodulin with an 
Igg concentration of 12 jjM. Haloperidol, which was at least as 
potent as TFP in the in v i t ro  pharmacology, was shown to in h ib i t  both 
control and MHS brain calmodulin with an I^g concentration of 500 pM. 
Observations such as these suggested tha t calmodulin antagonist drugs 
may have been acting at s ites other than calmodulin to induce th e ir  
e ffec ts  on the co n tra c t i le  cha rac te r is t ics  of skeletal muscle.
Balzer, Makinose and Hasselbach (1968) found that CPZ inh ib ited  
2+active Ca uptake by isolated SR. Andersson (1972) and Takagi 
(1981) both concluded that the major co n tra c t i le  e ffec ts  produced by
O i
CPZ in skeletal muscle f ib res  were mediated by the release of Ca*'
from the SR by th is  drug. Although calmodulin does not appear to be
?+involved in the regulation of the skeletal muscle SR Ca -ATPase
n o .
(Chiesi and C ara fo l i ,  1982), i t  may be involved in the regulation of 
2+
Ca^ release from the SR (Campbell and MacLennan, 1982; Chiesi and 
C a ra fo l i , 1983).
In th is  chapter investigations w i l l  be described which were designed 
to  investigate the e f fe c t  of calmodulin antagonists on isolated SR
membranes in re la t io n  to MH. These included the e ffec ts  of
2+ 2+ calmodulin antagonists on Ca -ATPase a c t iv i t y ,  ATP-dependent Ca
2+uptake and Ca e f f lu x .
4.2 Materials and Methods
4.2.1 Drugs and Reagents
The fo llow ing g i f t s  of drugs are g ra te fu l ly  acknowledged: TFP from
Smith, Kline and French Laboratories Austra lia ; t r i t i a t e d  TFP from 
Smith, Kline and French Research Laboratories, Hertfordshire , 
England; PRO and CPZ from May and Baker Austra lia  Pty Ltd; FPZ from 
E.R. Squibb and Sons; HPD from Searle Laboratories; PEN and PIM from 
Janssen Pharmaceutica, N.V., Belgium; and dantrolene sodium from 
Norwich Pharmaceuticals.
R24571 was obtained from Boehringer Mannheim, GmbH.
A ll other reagents were of analytica l grade.
4.2.2 Preparation of the Sarcoplasmic Reticulum Vesicles
Femoris muscle was removed from e ith e r control or MHS swine 
immediately post-mortem, ground and frozen in l iq u id  nitrogen. I t  
was stored at -70°C u n t i l  used.
I l l .
The frozen ground muscle was allowed to thaw in ice-cold 0.25 M 
sucrose, 10 mM Tris  (pH 7.4) (Tris-sucrose) before being homogenized 
in  a Waring blender (2x30 second homogenizations at low speed). All 
subsequent steps were carried out between 0° and 4°C. The homogenate 
was f i l t e r e d  through gauze and centrifuged at 3000xg fo r  5 minutes to 
remove m yo fib r i ls  and connective tissue . The supernatant was
centrifuged at 10,000xg fo r  20 minutes to remove mitochondria. The 
resu lt ing  supernatant was centrifuged at 100,000xg fo r  20 minutes to 
p e l le t  the membranes. This p e l le t  was washed with the same 
Tris-sucrose bu ffer and the resu lt ing  p e l le t  was resuspended in th is  
bu ffe r .  This preparation was referred to as the fragmented 
sarcoplasmic reticulum, (FSR) (Lau, Caswell and Brunschwig, 1977; 
White, Collins and Denborough, 1983).
4.2.3 Preparation of Ethyleneglycol-bi s-(J3-amino-ethyl ether )-N, 
N1-te traace ta te  Washed Sarcoplasmic Reticulum Vesicles
Fresh FSR preparations were resuspended in 0.25 M sucrose,
10 mM Tris  (pH 8 .0 ) ,  1 mM h is t id in e  and 1 mM ethyleneglycol-
bis-(J3~aminoethyl ether)-N, N '-te traaceta te  (EGTA) and allowed to 
stand in  ice fo r  15 minutes. The membranes were pelleted at 
100,000xg fo r  20 minutes and resuspended in Tris-sucrose bu ffe r.
4.2.4 The Calcium-Dependent Adenosine Triphosphatase Assays
Method a. The reaction buffer consisted of 100 mM KC1, 5 mM MgCl?,
0.5 mM EGTA, 20 mM h is t id in e  (pH 6 .8 ), 5 mM oxalate and 1 mM ATP.
0.5 ml of th is  bu ffe r was pipetted in to  tes t tubes standing in a 
water-ice s lu r ry .  To the appropriate tubes were added SR suspension 
(20-40 jjg p ro te in ), and 0.5 mM CaC^ or 1 mM EGTA. The reaction was 
started by immersing the tubes in a 37°C water bath. A fte r 10 minutes
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the reaction was stopped by the addition of 4 ml of inorganic
2+phosphate reagent. The Ca -dependent ATPase a c t iv i ty  was calculated
2+as the d iffe rence between the a c t iv i t y  in  the presence of added Ca 
and the a c t iv i ty  in the presence of EGTA.
Method b. The procedure followed in th is  method was the same as fo r
method a. except tha t the reaction bu ffe r consisted of 100 mM NaCl,
10 mM KC1, 10 mM MgCl2, 50 pM EGTA, 1 mM ATP and 10 mM Tri s (pH 7.4).
Also, CaC 12 was added at 10 jjM, 20 jjM, 30 pM and 40 pM to a series of
2+tubes to produce a Ca -dependent increase in a c t iv i ty .
4.2.5 The Adenosine Triphosphate-Dependent Calcium Uptake Assay
The reaction bu ffe r consisted of 100 mM KC1, 5 mM MgCl9, 10 mM Tris
(pH 7 .4 ), 5 mM oxalate and 20 pM CaCl^. To 0.45 ml of th is  bu ffer at
37°C were added ^C a^+ and SR vesic le suspension (75-100 pg p ro te in ).
The reaction was started by the addition of 1 mM ATP. 50 p i samples 
were withdrawn from the reaction medium at 15 seconds, 30 seconds, 50 
seconds and 120 seconds and f i l t e r e d  with 2 x 3 ml of ice cold 
reaction buffer on an Amicon f i l t r a t i o n  manifold. The f i l t e r s  used 
were of 0.22 pm pore size. A fte r f i l t r a t i o n  the f i l t e r s  were 
dissolved in 10ml  of s c in t i l la t io n  f lu id  and the ra d io a c t iv i ty  
present was counted in a l iq u id  s c in t i l la t io n  counter.
4.2.6 Passively Loaded Sarcoplasmic Reticulum Calcium E ff lux  Assay
The reaction bu ffer consisted of 100 mM KC1, 5 mM MgCl^, 10 mM Tris
(pH 7.4) and 1 mM CaCl^. Passive loading took place overnight 
between 0° and 4°C in a suspension of SR vesicles (1.5-3 mg protein 
in  1 ml of reaction buffer) in the presence of ^5Ca^+. E ff lux  
experiments were started by adding 50 p i of the preloaded vesicles to
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1.95 ml of reaction buffer at 37°C. 200 pi samples were withdrawn at 
0, 0.5, 1, 2, 5 and 10 minutes and were fi ltered with 2x3 ml of 
ice-cold reaction buffer on an Amicon fi l t ra t ion  manifold. Test 
drugs were added at t =15 seconds. The f i l te r s  used were of 22 pm 
pore size. After f i l t ra t ion  the f i l t e r s  were dissolved in 10 ml of 
scinti l lation fluid and the radioactivity present was counted in a 
liquid scinti l lation counter.
4.2.7 Ultraviolet Light-Activated Binding of Tritiated 
Trifluoperazine to Sarcoplasmic Reticulum Membrane Proteins
Samples of SR vesicles (1.5-3 mg protein) in 1 ml of 5 mM Tris (pH 
7.0), 1 mM MgCl  ^ were irradiated with UV light in the presence of 
^H-TFP (100-500 pM) and 500 pM Ca^+ for up to 90 minutes in an 
icebath with s t i rr ing. In some experiments a pre-irradiation in the 
presence of unlabelled TFP and 0.5 mM EGTA was included. Binding was 
assessed by separating the SR membrane proteins by polyacrylamide gel 
electrophoresis on 7.5% to 15% acrylamide gradient slab gels,si icing 
the gels into sections, and counting the radioactivity associated 
with each slice. Gel slices were dissolved in 30% overnight at 
60°C. 10 ml of scinti l lation fluid was added and the radioactivity 
was counted in a liquid scinti l lation counter.
4.2.8 Polyacrylamide Gel Electrophoresis
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS PAGE) 
was performed according to the method of Laemmli (1970) using 7.5% to 
15% acrylamide gradient slab gels with 4.5% acrylamide stacking gels. 
Gels were run at 40 ma/gel and stained with Coomassie blue.
1 1 4 .
4.2.9 Inorganic Phosphate Determinations
Inorganic phosphate was determined according to the method of 
Heinonen and Lahti (1981).
4.2.10 Protein Determinations
Protein determinations were performed using a modification of the 
Lowry method (Peterson, 1977).
4.2.11 S ta t i s t i c a l  Methods
Data was analysed by Student's t - t e s t  according to Hinchen (1969) or 
using the computer-based "S ta t i s t ica l  Package for the Social 
Sciences" (Nie, Hull, Jenkins, Steinbrenner and Bent, 1970).
4.3 Results
4.3.1 Fragmented Sarcoplasmic Reticulum 
2 +The Ca -dependent ATPase a c t iv i t i e s  of FSR preparations isolated 
from control and MHS porcine skeletal muscle did not d i f fe r  
s ignif icant ly  (Table 4.1) and were comparable to values reported by 
McIntosh, Berman and Kench (1977). Contamination of FSR preparations 
from our laboratory by mitochondria, lysosomes and sarcolemma have 
been shown to be low (White, Collins and Denborough, 1983).
Sodium dodecyl sulphate polyacrylamide gel electroDhoresis (SDS-PAGE) 
patterns showed similar protein compositions for both control and MHS 
FSR preparations (Figures 4.1 and 4.2).  The major protein bands in 
these gels correspond to the Ca -dependent ATPase (approximately 
100,000 MW) and the calcium binding protein calsequestrin
(approximately 66,000 MW) (White, Thomas and Denborough, 1983). A 
number of bands appear in the region of the MW of calmodulin
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Table 4.1
Control
Calcium-Dependent Adenosine Triphosphatase Act iv i t ies  of 
Fragmented Sarcoplasmic Reticulum Preparations Isolated 
from Control and Malignant Hyperpyrexia Susceptible 
Porcine Skeletal Muscle
ATPase A c t i v i t y  _n
(pmole P.. per minute per  
mg p r o t e i n ,  mean + S . E . )
1.18 + 0.1 15
MHS 1.24 + 0.07 9
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(approximately 17,000; Watterson, Sharief and Vanaman, 1980). 
Calmodulin was u n like ly  to be v is ib le  on th is  gel, however. 
Published estimates of the amount of calmodulin present in iso lated 
SR preparations (Chiesi and C a ra fo l i ,  1982) ind icate tha t 
approximately 50 ng of th is  protein was applied to the gel which is  
below the amount required to be detected by the sta in ing technique 
used here.
2+4.3.2 The E ffec t of Trifluoperazine on the Ca -Dependent Adenosine
Triphosphatase A c t iv i ty  of Fragmented Sarcoplasmic Reticulum
2+Trif luoperaz ine  inh ib ited  the Ca -dependent ATPase a c t iv i t ie s  o f
both control and MHS FSR with an I ^ q concentration of approximately
250 jjM (Figures 4.3 and 4 .4 ). The FSR ATPase a c t iv i ty  was almost
completely abolished at a TFP concentration of 500 j j M . Washing the
vesicles with a solu tion containing EGTA to remove calmodulin
associated w ith the outer surface of the vesicles had no e f fe c t  on
2+the extent of in h ib i t io n  of Ca -dependent ATPase a c t iv i ty  by TFP in  
e ith e r control or MHS FSR (Table 4 .2 ).
The e f fe c t  o f dantrolene sodium on the in h ib i t io n  of control and MHS 
2+FSR Ca -dependent ATPase a c t iv i ty  by TFP was investigated using the
Ca2+-ATPase assay method b (Materials and Methods 4 .2 .4 ). This
method used a f ixed  concentration of TFP (150 j j M ) to achieve
2+approximately 50% in h ib i t io n  of Ca -ATPase a c t iv i ty  over a range of 
2+Ca concentrations (zero to 4 0 jjM). I t  was considered that th is
method would have been more sensitive  in detecting any dantrolene
sodium reversal of TFP in h ib i t io n  than method a. which used a high 
2+Ca concentration. Dantrolene sodium had no e ffe c t on the
Figure 4.1 Polyacrylamide Gel Patterns of Fragmented Sarcoplasmic 
Reticulum Preparations Isolated from Malignant 
Hyperpyrexia Susceptible and Control Porcine Skeletal 
Muscle.
A. MHS
B. Control
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Figure 4.2 Comparison of Absorbance Scans of Polyacrylamide Gels of 
Control and Malignant Hyperpyrexia Susceptible Fragmented 
Sarcoplasmic Reticulum Preparations.
Wavelength = 540 nm.
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Figure 4.3 Inh ib ition  of Ca^+-Dependent ATPase A c tiv ities  of Control 
and Malignant Hyperpyrexia Susceptible Fragmented 
Sarcoplasmic Reticulum by Trifluoperazine, 
o Control 
• MHS
Each value is the mean +_ S.E. of 4 determinations. The 
differences between the results in the control and MHS 
preparations of FSR are not s ta t is t ic a lly  s ign ifican t.
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Figure 4.4 E ffec t of Dantrolene Sodium on the In h ib i t io n  of 
2+Ca -Dependent ATPase A c t iv i ty  of Control and Malignant 
Hyperpyrexia Susceptible Fragmented Sarcoplasmic 
Reticulum by Trif luoperaz ine.
o No addition □ 150 pM TFP ■ 150 pM TFP + 20 pM
dantrolene sodium
* 150 pM TFP value s ig n i f ic a n t ly  less than the no
addition value p < 0 .0 3
Each value is  the mean + S.E. of 3 determinations. No 
150 pM TFP + 20 pM dantrolene value is  s ig n if ic a n t ly  
d i f fe re n t  to the 150 pM TFP value.
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Table 4.2 The Effect of an Ethyl eneglycol-bis-(f3-ami noethyl ether)
-N,N'-tetraacetate wash on the Inhibition of Fragmented
Sarcoplasmic Reticulum 2+Ca -dependent Adenosine
Triphosphatase Activity Isolated from Control and
Malignant Hyperpyrexia Susceptible Porcine Skeletal
Muscle by Trifluoperazine
ATPase I n h i b i t i o n  by TFP 
(% c o n t r o l )
TFP c o n c e n tr a t io n  (jjM) 100 200 500
Control  FSR 30 55 99 
Control  EGTA-washed FSR 40 58 98 
MHS FSR 31 55 97
MHS EGTA-washed FSR 37 56 97
1 2 2 .
in h ib itio n  of control or MHS FSR Ca2+-dependent ATPase a c tiv ity  by 
150 jjM TFP (Figure 4.4).
4.3.2.1 U ltra -v io le t Light-Activated Irreversible Binding of 
T ritia ted  Trifluoperazine to the Proteins of the Fragmented 
Sarcoplasmic Reticulum
The highly reactive free radical species of phenothiazine drugs is
produced through oxidative metabolism, interaction with manganese or
melanin, or by irrad ia tion  of the dissolved drug with UV lig h t (Akera
and Brody, 1972). This free radical form of CPZ has been shown to
in h ib it brain sodium and potassium activated ATPase by binding
irrevers ib ly  to th is  protein (Akera and Brody, 1969, 1972).
Prozialeck, Cimino and Weiss (1981) used UV ligh t-activa tion  of
2+t r it ia te d  TFP to demonstrate a selective, Ca -enhanced and 
irrevers ib le  binding of th is labelled drug to calmodulin. 
U ltra -v io le t light-activated binding of tr it ia te d  TFP was used in the 
present study to investigate the protein spec ific ity  of interaction 
of TFP and FSR preparations, excluding calmodulin. The amount of 
calmodulin present in these preparations was too small to be 
identified  using th is technique.
In the present study FSR preparations isolated from control and MHS
2+muscle were irradiated with UV lig h t in the presence of Ca and 
tr it ia te d  TFP. The FSR proteins were then separated using SDS-PAGE, 
the gels were sliced and the rad ioactiv ity  associated with each slice 
was measured. No spec ific ity  of tr it ia te d  TFP interaction was 
observed in either control or MHS FSR preparations (Figure 4.5). The 
distributions of rad ioactiv ity along the gels correlated with the 
d is tribu tion of protein, the major protein component of the FSR being
Figure 4.5 Binding of UV Light-Activated Tritiated- 
Trifluoperazine to Control and Malignant Hyperpyrexia 
Susceptible Fragmented Sarcoplasmic Reticulum
Proteins.
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? +  2+  the Ca -dependent ATPase. In an attempt to saturate the Ca
-independent t r i t ia ted  TFP free-radical binding sites of the FSR,
control and MHS preparations were irradiated in the presense of
unlabelled TFP and EGTA. Further irradiation in the presence of
2+ 2+ t r i t ia ted  TFP and Ca failed to demonstrate any Ca -dependent
specificity of binding, and the amount of radioactivity associated
with the FSR proteins was reduced by half.
4.3.3 The Effects of R24571, Penfluridol, Pimozide, Fluphenazine,
Chlorpromazine, Promethazine and Haloperidol on the
2+Ca -Dependent Adenosine Triphosphatase of Fragmented
Sarcoplasmic Reticulum.
All the calmodulin antagonists tested in the present study (R24571,
PEN, PIM, TFP, FPZ, CPZ, PRO and HPD) inhibited the FSR Ca2+
-dependent ATPase activity of control and MHS muscle (Table 4.3).
2+Although individual drugs inhibited the Ca -dependent ATPase 
activity of the FSR to different degrees, the extent of this 
inhibition was similar in both control and MHS preparations.
Penfluridol (Figure 4.6) and R24571 (Figure 4.7) were the most potent 
2 +inhibitors of Ca -dependent ATPase activity (I^Q concentration 
approximately 20 jjM). The I^0 concentration for PIM was 80 pM 
(Figure 4.8), for TFP i t  was 250 j j M (Figure 4.3), for FPZ i t  was 
approximately 220 pM (Figure 4.9), for CPZ i t  was approximately 385 
pM (Figure 4.10) and for PRO and HPD i t  was greater than 500 pM 
(Figures 4.11 and 4.12, respectively).
1 2 5 .
2+Table 4.3 Calmodulin Antagonist Drug Inh ib ition  of Ca -Dependent
Adenosine Triphosphatase A ctiv ity  from Control and
Malignant Hyperpyrexia Susceptible Fragmented
Sarcoplasmic Reticulum.
FSR Published Published
Drug
ATPase
Control
J s o lü ü l
MHS
Calmodulin 
150 ^ _HM)
Octanol/Water 
P a r t i t io n  C oe ff ic ie n t
R24571 26 18 0.35
Pen flu r ido l 22 18 2.5 40,000,000
Pimozide 76 84 7 2,000,000
T r i f lu op e ra z in e 250 250 10 1,700,000
Fluphenazine 275 165 10 912,000
Chlorpromazine 500 270 42 191,000
Haloperidol 500 500 60 555,000
Promethazine 500 500 340 22,400
(For references see Tables 1.2 and 2.1)
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2+The e ffe c t of dantrolene sodium on the in h ib i t io n  of Ca -dependent
ATPase a c t iv i ty  of control and MHS FSR by HPD was investigated using
the Ca -dependent ATPase assay method b. (Materials and Methods
4 .2 .4 , Results 4.3.2) Contractures induced jn_ v i t ro  by HPD were
shown to be reversed by approximately 80% by dantrolene sodium in
both control and MHS muscle (Chapter 2 .3 .3 ) . The in h ib i t io n  of the 
2+FSR Ca -dependent ATPase a c t iv i ty  of control and MHS preparations by 
HPD, however, did not appear to be affected by dantrolene sodium 
(Figure 4.13).
4.3.4 The E ffects of Tr if luoperaz ine, Haloperidol and Penfluridol
2+on the Adenosine Triphosphate - Dependent Ca Uptake by
Fragmented Sarcoplasmic Reticulum.
2+The rates of ATP-dependent Ca uptake by FSR preparations isolated
from control and MHS porcine muscle did not d i f f e r  s ig n if ic a n t ly
(Figure 4.14). The calmodulin antagonists TFP (Figures 4.15 and
4.16), HPD (Figures 4.17 and 4.18) and PEN (Figures 4.19 and 4.20)
2+inh ib ited  ATP-dependent Ca uptake by the FSR. The extent of
in h ib i t io n  produced by these drugs was s im ila r in both control and
2+MHS preparations. Ca uptake rates were inh ib ited  by approximately 
50% by 150 pM TFP, 150 pM PEN and 500 pM HPD.
Dantrolene sodium had no s ig n if ic a n t  e ffe c t on the in h ib i t io n  of 
ATP-dependent Ca2+ uptake by 150 pM TFP (Figures 4.15 and 4.16) or 
500 pM HPD (Figures 4.17 and 4.18) in control or MHS FSR.
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Figure 4.6 Inhibition of Ca^+-Dependent ATPase Activities of Control 
and Malignant Hyperpyrexia Susceptible Fragmented 
Sarcoplasmic Reticulum by Penfluridol, 
o Control 
• MHS
Each value is the mean +_ S.E. of 3 determinations. The 
differences between the results in the control and MHS 
preparations of FSR are not s ta t is t ica l ly  significant.
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2+Figure 4.7 In h ib i t io n  of Ca -Dependent ATPase A c t iv i t ie s  of Control 
and Malignant Hyperpyrexia Susceptible Fragmented 
Sarcoplasmic Reticulum by R24571. 
o Control 
• MHS
Each value is  the mean +_ S.E. of 3 determinations. The 
differences between the resu lts  in the control and MHS 
preparations of FSR are not s ta t is t ic a l l y  s ig n if ic a n t .
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Figure 4.8 In h ib i t io n  of Ca^+-Dependent ATPase A c t iv i t ie s  of Control 
and Malignant Hyperpyrexia Susceptible Fragmented 
Sarcoplasmic Reticulum by Pimozide, 
o Control 
• MHS
Each value is  the mean + S.E. of 4 determinations. The 
differences between the resu lts  in the control and MHS 
preparations of FSR are not s ta t is t ic a l l y  s ig n if ic a n t .
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Figure 4.9 In h ib i t io n  of Ca^+-Dependent ATPase A c t iv i t ie s  of Control 
and Malignant Hyperpyrexia Susceptible Fragmented 
Sarcoplasmic Reticulum by Fluphenazine, 
o Control 
§ MHS
Each value is  the mean +_ S.E. of 3 determinations. The 
differences between the resu lts  in the control and MHS 
preparations of FSR are not s ta t is t ic a l l y  s ig n if ic a n t .
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Figure 4.10 Inhibit ion of Ca2+-Dependent ATPase Act iv i t ies  of Control 
and Malignant Hyperpyrexia Susceptible Fragmented 
Sarcoplasmic Reticulum by Chiorpromazine. 
o Control 
• MHS
Each value is  the mean + S.E. of 3 determinations. The 
differences between the resu l ts  in the control and MHS 
preparations of FSR are not s t a t i s t i c a l l y  s ign if ican t .
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Figure 4.11 In h ib i t io n  of Ca^+-Dependent ATPase A c t iv i t ie s  of Control 
and Malignant Hyperpyrexia Susceptible Fragmented 
Sarcoplasmic Reticulum by Haloperidol, 
o Control 
• MHS
Each value is  the mean +_ S.E. of 3 determinations. The 
d ifferences between the resu lts  in the control and MHS 
preparations of FSR are not s ta t is t ic a l l y  s ig n if ic a n t .
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Figure 4.12 In h ib i t io n  of Ca“ +-Dependent ATPase A c t iv i t ie s  of Control 
and Malignant Hyperpyrexia Susceptible Fragmented 
Sarcoplasmic Reticulum by Promethazine, 
o Control 
• MHS
Each value is  the mean + S.E. of 3 determinations. The 
d ifferences between the resu lts  in the control and MHS 
preparations of FSR are not s ta t is t ic a l l y  s ig n if ic a n t .
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Figure 4.13 E ffec t of Dantrolene Sodium on the In h ib i t io n  of 
2+Ca -Dependent ATPase A c t iv i ty  of Control and Malignant 
Hyperpyrexia Susceptible Fragmented Sarcoplasmic 
Reticulum by Haloperidol
o No addition □ 500 j j M HPD B 500 j j M HPD + 20 j j M
dantrolene sodium
* 500 j j M HPD value is  s ig n i f ic a n t ly  less than no
addition value p <0 .01
The differences between the resu lts  using 500 j j M HPD 
and 500 j j M HPD plus 20 j j M dantrolene sodium are not 
s ta t is t ic a l l y  s ig n if ic a n t .
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2 +Figure 4.14 The ATP-Dependent Ca Uptake by Control and Malignant 
Hyperpyrexia Susceptible Fragmented Sarcoplasmic
Reticulum, 
o Control 
• MHS
Each value is the mean +_ S.E. of 9 determinations. 
The differences between the results in the control and 
MHS preparations of FSR are not s ta t is t ica l ly
significant.
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Figure 4.15 In h ib i t io n  of ATP-Dependent Ca^+ Uptake of Control 
Fragmented Sarcoplasmic Reticulum by Trif luoperaz ine, 
o no addition (n=9) □ 150 jjM TFP (n=10)
■ 1 50 pM TFP + 20 jjM dantrolene sodium (n=3)
A 250 jjM TFP (n=6)
Values shown are means + S.E.
* 150 j j M TFP value s ig n i f ic a n t ly  less than no
addition value p <0.001
The differences between the resu lts  using 150 j j M TFP 
and 150 j j M TFP plus 20 j j M dantrolene sodium are not 
s t a t is t ic a l l y  s ig n if ic a n t .
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Figure 4.16 Inhibit ion of ATP-Dependent Ca^f Uptake of Malignant 
Hyperpyrexia Susceptible Fragmented Sarcoplasmic 
Reticulum by Trifluoperazine, 
o no addition (n=9) □ 150 jjM TFP (n=9)
■ 1 50 pM TFP + 20 jjM dantrolene sodium (n=3)
▲ 250 j j M TFP (n=7)
Values shown are means + S.E.
* 150 j j M TFP value s ignif icant ly  less than no
addition value p <0.002
The differences between the resu l ts  using 150 pM TFP 
and 150 pM TFP plus 20 pM dantrolene sodium are not 
s t a t i s t i c a l l y  s ignif icant .
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Figure 4.17 In h ib i t io n  of ATP-Dependent Ca^+ Uptake of Control 
Fragmented Sarcoplasmic Reticulum by Haloperidol, 
o no addition (n=9) □ 500 jjM HPD (n=3)
■ 500 pM HPD + 20 pM dantrolene sodium (n=3)
Values shown are means _+ S.E.
* 500 pM HPD value s ig n i f ic a n t ly  less than no
addition value p <0 .01
The differences between the resu lts  using 500 pM HPD 
and 500 pM HPD plus 20 pM dantrolene sodium are not 
s t a t is t ic a l l y  s ig n if ic a n t .
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Figure 4.18 In h ib i t io n  of ATP-Dependent Ca^+ Uptake of Malignant 
Hyperpyrexia Susceptible Fragmented Sarcoplasmic 
Reticulum by Haloperidol, 
o no addition (n =9) □ 500 pM HPD (n=3)
■ 500 jjM HPD + 20 jjM dantrolene sodium (n=3)
Values shown are means + S.E.
* 500 jjM  HPD value s ig n i f ic a n t ly  less than no
addition value p < 0 . 0 3
The differences between the resu lts  using 500 jjM HPD 
and 500 jjM HPD plus 20 jjM dantrolene sodium are not 
s ta t is t ic a l l y  s ig n if ic a n t .
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Figure 4.19 Inh ib ition  of ATP-Dependent Ca^ + Uptake of Control 
Fragmented Sarcoplasmic Reticulum by Penfluridol, 
o no addition (n=9) □ 1 50 j j M PEN (n=3)
Values shown are means + S.E.
* Significantly less than no addition value p<0 . 02
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Figure 4.20 In h ib i t io n  of ATP-Dependent CaL+ Uptake of Malignant 
Hyperpyrexia Susceptible Fragmented Sarcoplasmic 
Reticulum by P enflu r ido l, 
o no addition (n=9) □ 150 pM PEN (n =3)
Values shown are means +_ S.E.
* S ig n i f ic a n t ly  less than no addition value p<0.04
1 4 2 .
4.3.5 The Effects of Trifluoperazine and Haloperidol on the
2+Equilibrium E fflux  of Ca_____ from Fragmented Sarcoplasmic
Reticulurn.
2+The rates of e f f lu x  of Ca from passively loaded FSR preparations
iso la ted  from control and MHS porcine muscle did not d i f fe r
s ig n i f ic a n t ly  (Figure 4.21). When 150 pM TFP (Figures 4.22 and 4.23)
or 500 jjM HPD (Figures 4.24 and 4.25) were added to the e ff lu x
2+experiments at time = 15 seconds the rates of Ca e f f lu x  were 
s ig n i f ic a n t ly  accelerated in both control and MHS preparations.
Dantrolene sodium had no s ig n if ica n t e ffe c t on the acceleration of 
the e f f lu x  of Ca^+ caused by TFP (Figures 4.22 and 4.23) or HPD 
(Figures 4.24 and 4.25) from FSR preparations isolated from control 
or MHS muscle.
2+4.6.3 The E ffec t of Caffeine on the Ca -Dependent Adenosine
Triphosphatase A c t iv i ty  of Fragmented Sarcoplasmic Reticulum.
2+The e ffec t of caffe ine on the Ca -dependent ATPase a c t iv i t ie s  of
2+control and MHS FSR was investigated using the Ca -dependent ATPase
assay method b (Materials and Methods 4.2.4, Results 4 .3 .2 ) , since
?+there have been reports that caffeine inh ib ited  Ca -dependent ATPase 
a c t iv i t ie s  in skeletal muscle (Weber, 1968; Weber and Herz, 1968). 
In the present study, however, caffe ine had no e f fe c t  on control or 
MHS FSR Ca^+-dependent ATPase a c t iv i t ie s  (Figure 4.26).
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Figure 4.21 Calcium Efflux from Control and Malignant Hyperpyrexia 
Susceptible Fragmented Sarcoplasmic Reticulum, 
o Control (n=4)
• MHS (n =3)
Values shown are means + S.E.
The differences between the results in the control and 
MHS preparations of FSR are not s ta tis t ic a lly  
si gn ificant.
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2 +Figure 4.22 Acceleration of Ca Ef f lux  from Control Fragmented 
Sarcoplasmic Reticulum by Tr i f luoperazine,  
o no addit ion (n =4) □ 150 pM TFP (n=3)
■ 150 j j M TFP + 20 j j M dantrolene sodium (n=3)
Values shown are means + S.E.
* 150 jjM TFP value s ig n i f ic a n t l y  less than no
addit ion value p<0.04
** 150 j j M TFP value s ig n i f ic a n t l y  less than no
addit ion value p<0.006
The dif ferences between the results using 150 j j M TFP 
and 150 j j M TFP plus 20 j j M dantrolene sodium are not 
s t a t i s t i c a l l y  s ign i f ica n t .
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2+Figure 4.23 Acceleration of Ca E f f lux  from Malignant Hyperpyrexia 
Susceptible Fragmented Sarcoplasmic Reticulum by 
Tr i f luoperazine.
o no addit ion (n=3) □ 150 jjM TFP (n=3)
■ 150 jjM TFP + 20 jjM dan tro lene  sodium (n=3)
Values shown are means + S.E.
* 150 j jM  TFP value s ig n i f ic a n t ly  less than no
addit ion value p<0.005
The dif ferences between the resul ts  using 150 jjM TFP 
and 150 jjM TFP plus 20 jjM dantrolene sodium are not 
s t a t i s t i c a l l y  s ign i f ica n t .
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2+Figure 4.24 Acceleration of Ca E ff lux  from Control Fragmented 
Sarcoplasmic Reticulum by Haloperidol, 
o no addition (n=4) □ 5 0 0  jjM HPD (n=3)
■ 500 jjM HPD + 20 jjM dantrolene sodium (n=3)
Values shown are means + S.E.
* 500 jjM HPD value s ig n i f ic a n t ly  less than no
addition value p<0.04
** 500 j j M HPD value s ig n i f ic a n t ly  less than no
addition value p<0.002
The differences between the resu lts  using 500 jjM HPD 
and 500 jjM HPD plus 20 j j M dantrolene sodium are not 
s ta t is t i c a l l y  s ig n if ic a n t .
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2+Figure 4.25 Acceleration of Ca Efflux from Malignant Hyperpyrexia 
Susceptible Fragmented Sarcoplasmic Reticulum by 
Haloperidol .
o no addition (n=4) □ 500 j j M HPD (n=3)
■ 500 pM HPD + 20 pM dantrolene sodium (n=3)
Values shown are means +_ S.E.
* 500 pM HPD value s igni f icant ly  less than no
addition value p<0.02
** 500 pM HPD value s igni f icant ly  less than no
addition value p<0.003
The differences between the resul t s  using 500 pM HPD 
and 500 pM HPD plus 20 pM dantrolene sodium are not 
s t a t i s t i c a l l y  s igni f icant .
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Figure 4.26 E ffec t of Caffeine on the Ca^+-Dependent ATPase 
A c t iv i t ie s  of Control and Malignant Hyperpyrexia 
Susceptible Fragmented Sarcoplasmic Reticulum, 
o no addition (n=3) •  20 mM caffeine (n=3)
Values shown are means + S.E.
The differences between the resu lts  in the control and 
control plus 20 mM caffe ine values, and between the 
resu lts  in the MHS and MHS plus 20 mM caffe ine values 
are not s ta t is t ic a l l y  s ig n if ic a n t .
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4.4 Discussion
The resu lts  obtained in  th is  chapter showed that there were no
s ig n if ic a n t  differences in calcium transport charac te r is t ics  between
FSR preparations iso lated from control and MHS porcine skeletal 
2+muscle. The Ca -dependent ATPase a c t iv i t ie s  of control and MHS
preparations were not s ig n if ic a n t ly  d i f fe re n t ,  confirming e a r l ie r
reports (McIntosh, Berman and Kench, 1977; Niebroj-Dobosz and
Mayzner-Zawadzka, 1982; White, C o llins  and Denborough, 1983). The
2+rates of ATP-dependent Ca uptake did not d i f f e r  s ig n i f ic a n t ly  in 
control and MHS FSR preparations in agreement with three published 
reports (Nelson, Jones, Venable and Kerr, 1972; Denborough, H ird, 
King, Marginson, Mitchelson, Naylor, Rex, Zapf and Condron, 1973; 
White, Collins and Denborough, 1983). Other authors have observed 
MHS SR Ca^+ uptake to be reduced (McIntosh, Berman and Kench, 1977; 
Nelson, 1978; Gronert, Heffron and Taylor, 1979) or increased (Berman 
and Kench, 1973; Brucker, Williams, Popinigis, Galvez, Vail and 
Taylor, 1973; B r i t t ,  Endrenyi and Cadman, 1975) when compared to 
control SR preparations. These differences might be due to the
various methods used to iso la te  the SR membranes and to quantita te
2+ 2+Ca uptake by these preparations. The equilibrium Ca e f f lu x
cha rac te r is t ics  of control and MHS FSR preparations were not
s ig n i f ic a n t ly  d i f fe re n t ,  in agreement with an e a r l ie r  published
report (White, Collins and Denborough, 1983).
2+Caffeine causes contracture in skeleta l muscle by releasing Ca
from the SR (Ogawa, 1970). I t  had also been reported tha t caffe ine
2+ 2+ inh ib ited  the SR Ca uptake by in h ib i t in g  the SR Ca -dependent
ATPase a c t iv i t y  of skeletal muscle (Weber, 1968; Weber and Herz,
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1968). The present study, however, did not detect any inhibition of 
?+the Ca -dependent ATPase activities of control or MHS FSR. Thus, an
2+inhibition of the Ca -dependent ATPase activity by caffeine was not 
involved in the induction of in_ vitro caffeine contractures in 
control or MHS porcine skeletal muscle. The difference in results 
between the earlier study (Weber, 1968) and the present investigation 
may have been due to the fact that Weber (1968) used frog skeletal 
muscle as the source of the SR membranes and carried out the ATPase 
assay at 24°C.
2+The Ca transport characteri sti cs of control and MHS FSR
preparations did not differ in their responses to a range of drugs
used in the present investigation as calmodulin antagonists.
2+Calmodulin antagonist drugs inhibited the Ca -dependent ATPase
2+ 2+ activity and ATP-dependent Ca uptake of, and accelerated the Ca
efflux from, both control and MHS FSR to a similar extent.
2+Trifluoperazine induced these effects on FSR Ca transport at 
concentrations comparable to those reported for rabbit skeletal 
muscle SR (Campbell and MacLennan, 1982; Ho, Scales and Inesi, 1983).
The skeletal muscle relaxant dantrolene sodium did not reverse the 
effects of calmodulin antagonist drugs on control and MHS FSR 
Ca^+-dependent ATPase activity, ATP-dependent Ca^+ uptake or Ca^+ 
efflux. This observation was consistent with a report that
dantrolene sodium had no effect on these SR Ca^+ transport functions, 
in the absence of any drug, in control and MHS FSR preparations
(White, Collins and Denborough, 1983).
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2+ ? +The Ca -dependent ATPase activity and ATP-dependent Ca uptake of
skeletal muscle SR have been shown to be calmodulin-independent
(Chiesi and Carafoli, 1982). The mechanism of action by which the
calmodulin antagonist drugs accelerated the efflux of Ca from
isolated FSR membranes may, however, have involved a specific
interaction with calmodulin. Campbell and MacLennan (1982) and
Chiesi and Carafoli (1983) have proposed that calmodulin may be
2+involved in the release of Ca from the SR. These proposals
followed the observation of the calmodulin-dependent phosphorylation 
of a number of proteins associated with the SR membrane. I t  has been 
shown that these phosphoproteins did not interact directly with 
calmodulin, that the calmodulin-dependent kinase responsible for the 
phosphorylation of these proteins was membrane bound, and that at 
least one of these phosphoproteins was dephosohorylated by a 
calmodulin-dependent phosphatase activity (Chiesi and Carafoli, 
1983). The exact function of the calmodulin-dependent kinase 
activity associated with the SR membrane has, however, yet to be 
determined.
All of the calmodulin antagonist drugs tested in the present
investigation inhibited the Ca -dependent ATPase activity of FSR
preparations isolated from control and MHS porcine skeletal muscle,
but with I^Q concentrations much higher than those reported for the
inhibition of a calmodulin-dependent function by these drugs (Tables
1.2 and 4.3). The inhibition of ATP-dependent Ca^+ uptake by, and
2+the acceleration of Ca efflux from, control and MHS FSR also 
required high concentrations of these drugs. These observations were 
consistent with the findings of Chiesi and Carafoli (1982) that the
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2+ 2+Ca -dependent ATPase and the ATP-dependent Ca uptake of skeletal
muscle SR were calmodulin-independent.
There are other possible mechanisms by which the calmodulin
2+antagonist drugs might effect the Ca transport characteristics of
the SR membrane. One site of action proposed for TFP in skeletal
muscle SR involved the 53,000 MW glycoprotein associated with
isolated SR vesicles (Michalak, Campbell and MacLennan, 1980). This
glycoprotein was present in a constant molar ratio with the 
2+Ca -dependent ATPase enzyme of the SR and showed many similarities
to the glycoprotein component of the sodium and potassium ATPase
complex of the sarcolemma (Campbell and MacLennan, 1981). Chiesi and
Carafoli (1982) proposed that the inhibition of the SR Ca^+-dependent
ATPase activity by TFP was correlated with the interaction of the
drug with this glycoprotein, abolishing a glycoprotein mediated
stimulation of ATPase activity. In the present investigation
ultra-violet light-activated irreversible binding of tritiated TFP to
the proteins of FSR preparations isolated from control and MHS muscle
did not detect any specific TFP-protein interactions, however. The
highly reactive TFP free radical appeared to bind to all the proteins
present in these FSR preparations. This observation did not rule out
a direct interaction between TFP and a protein or proteins to bring
about its effects (for example, the 53,000 MW glycoprotein or the 
2+Ca -dependent ATPase enzyme itself), but suggested that these 
interactions may be non-specific.
The relatively high concentrations of calmodulin antagonist drugs
2+required to achieve substantial inhibition of the FSR Ca -dependent
2+ 2+ATPase and ATP-dependent Ca uptake, and acceleration of Ca efflux
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from the FSR, suggested a non-specific effect of these drugs on this
isolated membrane fraction. The well documented membrane effects of
highly hydrophobic drugs such as the calmodulin antagonists may be
2+sufficient to explain their effects on the SR Ca transport
functions (Guth and Spirtes, 1964; Seeman, 1972 and 1977; 
Frisk-Holmberg and Kleijn, 1972). The partitioning of large 
concentrations of calmodulin antagonist drugs into the FSR membranes
seemed likely. Seeman (1977) observed that an aqueous phase
-5 -6concentration of CPZ of 10 M or 10 M established a membrane phase
concentration of 20 mM. This amount of partitioning may effect SR
2+membrane permeability or simply render i t  leaky to Ca . Ho, Scales
and Inesi (1983) concluded that the inhibition by TFP of the SR
2+ 2+Ca -dependent ATPase activity and ATP-dependent Ca uptake of
rabbit skeletal muscle were due to structural perterbations induced
by the drug partitioning into the SR membrane. These authors have
demonstrated ultrastructural alterations including SR membrane
thickening and loss of granular detail on the outer surface of SR
vesicles in the presence of TFP. Also, because of the highly
hydrophobic nature of the calmodulin antagonist drugs, they may
interact directly with the hydrophobic regions of membrane proteins 
2+such as the SR Ca -dependent ATPase enzyme.
4.5 Summary
The calmodulin antagonist drugs affected the contractile
characteristics of both control and MHS skeletal muscle in vitro at 
concentrations which might produce disruption of the Ca^+ transport 
functions of the SR. These effects were studied using fragmented SR 
preparations isolated from control and MHS porcine skeletal muscle.
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?+ ?+ The FSR Ca -dependent ATPase activities and ATP-dependent Ca
24-
uptake rates and the rates of efflux of Ca from FSR isolated from 
control and MHS porcine skeletal muscle did not differ significantly.
A range of calmodulin antagonist drugs inhibited the FSR
2+ 2+Ca -dependent ATPase activity and ATP-dependent Ca uptake, and
2+accelerated the efflux of Ca from FSR preparations isolated from
control and MHS muscle. The extent to which the calmodulin
2+antagonist drugs affected these FSR Ca transport functions was 
similar in both control and MHS preparations.
2+The dissruption of the Ca transport functions of both control and 
MHS FSR by calmodulin antagonist drugs was probably due to a 
combination of the following mechanisms:
a) specific interaction with a calmodulin-dependent function 
such as the calmodulin-dependent protein kinase system 
associated with the SR
b) other specific interactions such as binding to the 53,000 MW
2+glycoprotein associated with the Ca -dependent ATPase enzyme
c) non-specific interactions with SR membrane lipids and 
proteins due to the highly hydrophobic nature of these drugs.
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CHAPTER 5 THE NEUROLEPTIC MALIGNANT SYNDROME AND MALIGNANT 
HYPERPYREXIA.
5.1 Introduction
The Neuroleptic Malignant Syndrome (NMS) was f i r s t  recognized as a 
serious side e f fe c t  of neuroleptic therapy in psych iatric  patients in 
1960 (Delay, Pichot and Lemperiere, 1960). The symptoms of NMS are 
s im ila r  to those of MH (Table 5.1) and include hyperpyrexia, 
hyperton ic ity , tachycardia, an elevated serum CPK and la b i le  blood 
pressure (Caroff, 1980). Although the incidence of NMS was not 
known, the number of cases found in a series of several hundred 
psych ia tr ic  patients suggested an incidence of 0.5-1% (Delay, Pichot 
and Lemperiere, 1963). The m orta l i ty  rate fo r  NMS has been estimated 
at 30% (Burke, Fahn, Mayeux, Weinberg, Louis and W iliner, 1981).
The neuroleptic drugs which have been implicated in causing NMS 
episodes are of the high potency class and include haloperidol 
(Weinberg and Ke lly , 1977; Feibel and S ch iffe r, 1981), phenothiazines 
such as fluphenazine (Allan and White, 1972), chlorpromazine (Morris, 
McCormick and Reinarz, 1980) and tr i f luope raz ine  (Smego and Durack, 
1982), th iothixene (Weinberg and Twersky, 1983), and combinations of 
the above drugs (Oppenheim, 1973). Phenothiazines in conjunction 
with morphine (Bleichner, Squara and Parent, 1981) and alcohol 
(Freed, 1981) have also been implicated in the genesis of NMS.
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Table 5.1 Clinical and Biochemical Similarities Between Malignant 
Hyperpyrexia and the Neuroleptic Malignant Syndrome.
Hyperpyrexia
Hypertonicity of Skeletal Musculature
Tachycardia
Tachypnoea
Hyperkalaemia
Metabolic Acidosis
Elevated Serum Creatine Phosphokinase 
Response to Dantrolene Sodium
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In some cases, once the symptoms of NMS have resolved, neuroleptic 
medication has been reintroduced with no recurrence of symptoms 
(Burke, Fahn, Mayeux, Weinberg, Louis and W illner, 1981; S ca r le tt ,  
Zimmerman and Berkovic, 1983; Mueller, Vester and Fermaglich, 1983). 
This observation indicated that ind iv idua l physiological and 
environmental factors  may be important in  NMS, and th is  was supported 
by the comparatively well-known occurence of neuroleptic induced 
heat-stroke in psych ia tr ic  patients exposed to high environmental 
temperatures ( E l l io t  and Brow, 1973; Sarnquist and Larsen, 1973; Mann 
and Boger, 1978).
The diagnosis of NMS was complicated by the non-drug re lated syndrome 
'acute le tha l catatonia ' (Feldman, 1984). This syndrome was
described well before the in troduction  of neuroleptic therapy 
(Stauder, 1934) and can resemble NMS close ly (Gelenberg, 1976).
A number of investigators have proposed central mechanisms as the 
cause of NMS. These include dysfunction of the basal ganglia and 
possibly of the hypothalamus (Morris, McCormick and Reinarz, 1980). 
dopamine receptor blockade (Henderson and Wooten, 1981), dopamine 
depletion (Burke, Fahn, Mayeux, Weinberg, Louis and W illner, 1981) 
and a combination of in h ib i t io n  o f norepinephrine and dopamine 
reuptake together with blockade of post-synaptic dopamine receptors 
(Ansseau, D ir icq , Grisor and Collard , 1980). The s t r ik in g
symptomatic likeness between NMS and MH has led other investigators  
to consider the re la tionsh ip  between these two syndromes. Weinberg 
and Twersky (1983) proposed that NMS patients should be considered as 
candidates fo r  developing MH in tra o p e ra t iv e ly . Other investigators  
have studied blood samples or muscle biopsy specimens in  order to
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establish a pos it ive  l in k  between NMS and MH. Some of these studies 
have re lied  on tests which were not re l ia b le  as diagnostic tests fo r  
MH. These included the p la te le t  ATP depletion tes t (S car le tt, 
Zimmerman and Berkovic, 1983) and a muscle phosphorylase ra t io  
determination (Burke, Fahn, Mayeux, Weinberg, Louis and W illner, 
1981). Only three NMS patients have been reported as being tested 
fo r  MH s u s c e p t ib i l i ty  using an v i t ro  muscle contracture tes t .  
Caroff, Rosenberg and Gerber (1983) observed that muscle from th e ir  
NMS patient developed a contracture of 5g on exposure to 1.2% 
halothane, but observed no response to caffe ine. The diagnosis of 
th is  patient was MH pos it ive . Tollefson (1982) reported a NMS 
patient whose muscle displayed no abnormal responses to halothane or 
to  halothane plus caffe ine. S u sce p tib i l i ty  to MH was also ruled out 
in a NMS patient reported by S ca r le tt ,  Zimmerman and Berkovic (1983; 
Moulds, 1983, personal communication). This pa t ie n t 's  muscle 
displayed normal responses to halothane, ca ffe ine , succinylcholine 
and potassium ch lo ride .
Another feature of NMS which indicated a re la tionsh ip  with MH was the 
reported e ff icacy of dantrolene sodium, the muscle relaxant regarded 
as a specific  treatment fo r  MH (Austin and Denborough, 1977; Kolb, 
Horne and Martz, 1982), in the treatment of NMS. Dantrolene sodium 
has been used e f fe c t iv e ly  in NMS by both the oral (Coons, Hillman and 
Marshal, 1982; Delacour, Daoudal, Chapoutot and Rocq, 1981) and the 
intravenous route (Goekoop and Carbaat, 1982).
5.2 Report of a case of Neuroleptic Malignant Syndrome.
The fo llowing case report describes the occurance of NMS in a 
psych ia tr ic  patient re ffered to Royal Canberra Hospital, Acton,
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A.C.T. The pa t ien t ,  Mr. R.M., was subsequently ident if ied  as MHS by 
in v i t ro  muscle contracture tes t ing  (Denborough, Collins and 
Hopkinson, 1984).
Mr R.M. was aged 31 years and was diagnosed as a chronic 
schizophrenic in October 1982. He was being treated with 
fluphenazine hydrochloride (5 mg twice a day), fluphenazine decanoate 
(50 mg intramuscularly once weekly) and benzhexol hydrochloride (2.5 
mg twice a day). On the 9th of July, 1983, Mr R.M. complained of 
nausea and feeling dizzy. He vomited twice, and on the second 
occasion the vomitus contained coffee-ground material.  The patient 
was admitted to hospital and soon a f te r  he had a grand mal f i t .  His
blood pressure was 170/110 and his temperature was 38.5°C. No
abnormality was found on clinical  examination of the nervous system, 
and he remained drowsy and febr i le  for the next two days. His serum 
creat ine phosphokinase was 53,000 units/1 (normal range 10 to 150 
units /1) and his urine contained myoglobin. A diagnosis of the 
neuroleptic malignant syndrome was made and his drug treatment was 
stopped. The patient  was t reated symptomatically and made an
uneventful recovery.
Two months l a t e r ,  Mr R.M. was feeling f i t  and well,  and his mental 
symptoms had not deteriorated without drug treatment. On clinical  
examination no abnormality was found and his serum creatine 
phosphokinase was 87 units /1 .  J_n vi tro  muscle t e s ts  on the 27th of 
September, 1983 showed increased muscle co n trac t i l i ty  diagnostic of 
suscep t ib i l i ty  to malignant hyperpyrexia (Figure 5.1).
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Figure 5.1 Diagnostic Muscle Contracture Testing of Patient R.M. 
showing Positive Reactions.
The muscle was vastus la tera l is .
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On the 29th of November, 1983, Mr R.M.'s brother, Mr G.M., was also 
diagnosed as MHS on in v i t ro  muscle tes t ing .
There were no gross abnormalities observed by histological 
examination of Mr R.M.'s vastus l a t e r a l i s  muscle (Figure 5.2), 
although the muscle f ib res  appeared to be s l igh t ly  larger than normal 
and displayed some Type I (dark staining) f ibre  clumping (Hopkinson, 
1984, personal communication).
5.3 Piscussion
The above case report of a NMS episode in a psychiatr ic patient  and 
his subsequent iden t i f ica t ion  as MHS supports the theory that  NMS and 
MH are related syndromes. Other reports of in vitro skeletal muscle 
tes t ing  of NMS patients  have shown that  one out of a tota l  of three 
patients  was MHS (posit ive - Caroff, Rosenberg and Gerber, 1983; 
negative - Tollefson, 1982 and Sca r le t t ,  Zimmerman and Berkovic, 
1983). This observation was consistent with the i_n vi tro 
pharmacological finding that  neuroleptic drugs acted on both control 
and MHS porcine skeletal muscle (Chapter 2). These drugs caused 
contractures in and also potentiated the hypercontracti l ity  of MHS 
muscle. They also caused contracture in control muscle, and induced 
i t  to become hypercontracti 1 e and behave in a similar way to MHS 
muscle.
The observations on the efficacy of dantrolene sodium in the 
treatment of three cases of NMS (Coons, Hillman and Marshal, 1982; 
Delacour, Daoudal, Chapoutot and Rocq, 1981; Goekoop and Carbaat, 
1982) does not necessarily  mean these cases were all MHS individuals.
Figure 5.2 Histological Appearance of Vastus Lateralis Muscle of 
patient R.M. NADH-tetrazoliurn reductase stain, x 50 
(a) normal control (b) Patient R.M.
Micrographs were kindly supplied by Mr K. Hopkinson.
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In v i t r o  pharmacology of the neuroleptic drugs (Chapter 2) has shown
tha t dantrolene sodium had the a b i l i t y  to reverse contractures
induced by neuroleptics in both control and MHS porcine muscle. The
e ff icacy  of dantrolene sodium in the treatment of MH and NMS may
re f le c t  a s im ila r c e l lu la r  mechanism of p rec ip ita t ion  of both these
2+syndromes, tha t is ,  high intramyoplasmic Ca levels in MH, 
MH-related NMS and non-MH-related NMS.
The jn_ v i t r o  pharmacological e ffec ts  of neuroleptic drugs were 
observed at concentrations in  the pM range (Chapter 2). The 
concentration of neuroleptic drug in a pa tien t 's  serum water, 
however, has been shown to be in the range 0.1 to 50 nM although th is  
f ig u re  was only 5% of the to ta l plasma concentration in the case of 
CPZ. The other 95% of the drug was bound to plasma proteins (Seeman, 
1977; Verbeek, Cardinal, H i l l  and Midha, 1983). Due to the 
hydrophobicity of neuroleptic drugs they are very soluble in
membranes. In the case of CPZ, an aqueous phase concentration of
-5 -610 M or 10 M established a membrane phase concentration of 20 mM 
(tha t is ,  20 mmoles of drug per kg or l i t r e  of membrane phase)
(Seeman, 1972). Also to be taken in to  account was the actual
concentration of drug present in a typ ica l pharmacological or 
biochemical experiment. In the case of CPZ, 20-90% of the drug may 
have been absorbed to the tissue and glassware present (Seeman, 
1977). These considerations suggest that the concentration of
neuroleptic drugs reached in membranes _i_n vivo may have been high 
enough to produce the e ffec ts  observed in v i t ro .
The mechanism by which neuroleptic drugs produce an NMS episode may 
involve many s ites of action in both MHS and non-MHS ind iv idua ls .
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2+The most important of these appeared to be the SR Ca regulatory
mechanisms of skeletal muscle. Neuroleptic drugs inhibited the
uptake of Ca from the myoplasm and also caused the release of
stored Ca from the SR (Chapter 4) thereby raising myoplasmic Ca
levels. This effect might trigger MH in MHS individuals and also
raise Ca levels high enough to trigger a MH-like syndrome (that is,
NMS) in non-MHS individuals. The observation that dantrolene sodium
reversed neuroleptic-induced contractures _i_n vitro (Chapter 2) while
2+being unable to affect either the inhibition of SR Ca uptake or
2+acceleration of Ca release produced by neuroleptic drugs (Chapter 
4) suggested some other site of action. Since dantrolene sodium is 
thought to act on excitation- contraction coupling (Ellis and Bryant, 
1972), neuroleptic drugs may also act at that site. 
Calmodulin-dependent functions were also inhibited by neuroleptic 
drugs (Levin and Weiss, 1976).
Another factor contributing to both MH related and non-MH related NMS 
was the effect of neuroleptics on both the central and peripheral 
mechanisms of thermoregulation (Kolli as and Bullard, 1964). Once 
hyperpyrexia begins, the inhibition of heat loss mechanisms by these 
drugs would exacerbate the situation. Individual physiological and 
environmental conditions were likely to be important in the genesis 
of a NMS episode. A psychiatric patient receiving neuroleptic 
therapy who was agitated or restrained, or who was exposed to high 
environmental temperatures may be at risk.
The drugs PEN and PIM have been shown to differ from the other 
neuroleptics tested in their i_n vitro muscle pharmacology (Chapter 
2). Unlike the other drugs, PEN and PIM did not induce contracture
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in e i ther  control or MHS porcine muscle, nor did they induce
hypercontracti l ity  in control muscle. These observations may have
c lin ica l  implications i f  i t  can be shown that  PEN and PIM do not
produce NMS i_n vivo in the psychiatr ic patient population. These
drugs were, however, among the most potent calmodulin antagonists
2+studied, and both induced marked effects  on the Ca transport
functions of isolated FSR preparations from both control and MHS 
porcine muscle. The fa i lu re  of PEN and PIM to induce in vitro 
contracture may have been due to the i r  insolubil i ty  in the aqueous 
organ bath environment. Pimozide was one of two neuroleptics being 
taken by a patient  who developed NMS, but since the other drug was 
HPD, no conclusions can be drawn as to PIM's safety (Ansseau, Diricq, 
Grisar and Col lard,  1980). Penfluridol has not been reported in 
conjunction with NMS. Since both PEN and PIM are recently introduced 
neuroleptics, more time will be needed to evaluate them in 
psychiatr ic prac t ice .
5.4 Summary
Some neuroleptic drugs can t r igger  MH in susceptible individuals.
They are, however, much weaker t r iggers  than halothane or
succinylcholine. The psychiatr ic patient  population is  exposed to
chronic and high dose treatment with neuroleptics and MHS individuals
may be at r i sk .  Neuroleptic drugs also appeared to be able to
prec ip i ta te  a MH-like syndrome in non-MHS individuals through the ir
2+effects  on muscle Ca regulatory mechanisms.
CHAPTER 6 GENERAL DISCUSSION
The basic abnormality in human and porcine MH is  not known, but i t  is
?+thought to involve a disturbance of myoplasmic Ca regulation
(Denborough, 1980). Thus, in v ivo , tr ig ge rs  of MH such as halothane
2+prec ip ita te  a rapid and sustained r ise  in myoplasmic Ca levels in
MHS skeletal muscle leading to the acute MH reaction. This 
2+abnormality of Ca regulation in MHS muscle is  also observed in in
v i t ro  pharmacological muscle s t r ip  preparations as a
h yp e rco n tra c t i l i ty  to 3% halothane, 2 mM caffe ine , 1 mM
succinylcholine and 80 mM potassium ch loride. The major ro le  in
2+regula ting myoplasmic Ca concentrations is  played by the SR through
2 + 2+i t s  properties of uptake, storage and release of Ca . These Ca
storage and transport a c t iv i t ie s  control the con trac t i le  a c t iv i ty  and
much of the metabolism of the muscle f ib re .  The SR receives the
2+signal to release Ca , and therefore i n i t i a t e  contraction, through
the E-C coupling mechanism. The de ta ils  of th is  mechanism are not
known, but i t  occurs at the t r ia d  junction of the SR and the t- tubu le
where depolarization of the t- tubu le  membrane stimulates the SR to 
2+release Ca . I t  is  the E-C coupling mechanism which has been
proposed as the s ite  of the basic abnormality in MH skeletal muscle
(Austin and Denborough, 1977; Denborough, 1980; Okumura, Crocker
and Denborough, 1980). In the present investigation the ro le  of the 
2+Ca -regulatory protein calmodulin in MH was studied using the 
porcine MH model. This was achieved by studying the in v i t ro  muscle 
pharmacology and biochemistry of calmodulin antagonist drugs and by 
studies of isolated calmodulin. I t  is  not known whether calmodulin 
is  involved in E-C coupling, although i t  has been proposed that
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calmodulin plays a role in the excitation-secretion coupling of 
synaptic transmission in neural tissue (Roufogalis, 1980).
The observations on the in vitro muscle pharmacology and biochemistry
of calmodulin antagonist drugs made in the present investigation
2 +suggested that the Ca regulatory protein calmodulin is not the 
specific site of action through which these drugs induced changes in 
the contractile characteristics of control and MHS porcine skeletal 
muscle. Also, physical and functional studies of calmodulin 
preparations isolated from control and MHS porcine brain did not show 
any differences between these proteins. These observations were 
consistent with other physical (Lorkin and Lehmann, 1983) and
functional (Marjanen, Collins and Denborough, 1984) comparisons of 
control and MHS calmodulins. These findings suggest that calmodulin 
is not abnormal in porcine MHS tissue, and that calmodulin does not 
play a role in the hypercontractility of MHS muscle.
In an i_n_ vitro pharmacological muscle strip preparation the 
calmodulin antagonist drugs induced changes in the contractile 
characteristics of both control and MHS porcine skeletal muscle. The 
calmodulin antagonist drugs induced contracture in both control and 
MHS muscle, induced hypercontractility to halothane, caffeine and 
succinylcholine in control muscle, and also potentiated 
hypercontractility to halothane, caffeine and succinylcholine in MHS 
muscle. These changes were consistent with the calmodulin antagonist
24 -drugs causing an increase in myoplasmic Ca concentration in both 
control and MHS muscle. This proposal is also consistent with the 
observed effects of the calmodulin antagonist drugs on isolated FSR
24 -preparations. That is ,  these drugs inhibited the SR Ca -dependent
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2+ATPase activity and ATP-dependent Ca uptake, and accelerated the
24-efflux of Ca1" , from both control and MHS FSR preparations. Two of
2+the calmodulin antagonist drugs that affected the SR Ca1" transport 
functions, PEN and PIM, did not affect the i_n vitro contractile 
characteristics of control or MHS muscle. This may have been because 
PEN and PIM were insoluble in the organ bath solution. The activity 
of PEN and PIM in the biochemical experiments may have been due to 
the direct exposure of the FSR to the incubating medium containing 
these drugs.
The calmodulin antagonist drugs used in the present investigation did
not provide calmodulin-specific antagonist activity in either the
pharmacological muscle strip preparation or the isolated SR membrane
preparation. These observations reinforce the growing recognition of
the non-specific effects of the calmodulin antagonist drugs which are
presently available when used in cellular systems or complex
sub-cellular systems, especially in the presence of biological
membranes (Corps, Hesketh and Metcalfe, 1982; Roufogalis,
Minocherhomjee and Al-Jabore, 1983). The inhibitory activities of
2+the calmodulin antagonist drugs with respect to the SR Ca -dependent 
ATPase activity of both control and MHS porcine skeletal muscle was 
correlated with the octanol/water partition coefficient of each drug.
The i_n vitro contractile responses of control and MHS muscle to 
potassium chloride, in contrast to the responses to halothane, 
caffeine and succinylcholine, were not affected by the calmodulin 
antagonist drugs. This observation may have been explained by the 
ability of calmodulin antagonist drugs to reduce the excitability of 
excitable membranes such as the sarcolemma (Langslet, 1970; Seeman,
169 .
1972). The reason why responses to succinylcholine were not affected 
by this electrical stabilization of the sarcolemma may have been that 
succinylcholine interacted with the sarcolemma at a specific membrane 
receptor (that is ,  the acetylcholine receptor), while potassium 
chloride did not. Succinylcholine may have also had a direct effect 
on the SR (Moulds, 1978). The observation that in vitro contractile 
responses of control and MHS muscle to halothane and caffeine were 
not affected by the electrical stabilization of the sarcolemma by 
calmodulin antagonist drugs suggested that halothane and caffeine 
acted at a site distal to the sarcolemma. Caffeine has been thought 
to cause in vitro contracture by acting directly on the SR causing 
the release of stored Ca (Ogawa, 1970), and this is consistent with 
these observations. The evidence in favour of the SR as a site of 
action for halothane has been conflicting, however, and i t  may be 
that halothane affects the E-C coupling mechanism (Moulds and 
Denborough, 1974a; Nelson and Denborough, 1977).
Because of the observations that calmodulin antagonist drugs induced 
MH-like hypercontractility in control porcine skeletal muscle and 
potentiated the hypercontracti1ity of MHS muscle in v i t ro , i t  would 
be interesting to investigate the _i_n vivo effects of these drugs on 
control and MHS swine. Further experimentation might include an 
investigation of whether or not calmodulin antagonist drugs trigger a 
MH episode in MHS swine, and whether or not these drugs induce 
MH-like symptoms in control swine. Also, the in vivo responses of 
control swine to halothane and succinylcholine after administration 
of calmodulin antagonist drugs might be studied. Some of these 
experiments have been fortuitously carried out already at low 
calmodulin antagonist doses since the premedication which was
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administered to both control and MHS swine in the present study 
(STRESNIL; Smith, Kline and French Laboratories, Austra lia) 
contained the butyrophenone azaperone. Azaperone is  s tru c tu ra l ly  
very s im ila r to the butyrophenone HPD. None of the control or MHS 
swine reacted adversely to intramuscular in je c t io n  of 1.5-2 mg/kg 
azaperone. Higher doses or chronic administration experiments using 
calmodulin antagonist drugs may have provided d if fe re n t re su lts .
The possible ro le  of calmodulin antagonist drugs in p re c ip ita t in g  
human MH has attracted recent in te res t through investigations of NMS, 
a l i fe - th re a te n in g  s ide -e ffec t of neuroleptic therapy (especia lly  
using the phenothiazine and butyrophenone drug groups) that closely 
resembles an MH episode. Observations presented in  the present 
investiga tion  and elsewhere (Caroff, Rosenberg and Gerber, 1983) have 
shown that chronic, high dose neuroleptic therapy may p rec ip ita te  a 
MH episode in  MHS ind iv id ua ls . Patients who had experienced a NMS 
episode and who were diagnosed as MH-negative (Tollefson, 1982; 
S ca r le tt ,  Zimmerman and Berkovic, 1983) may have been affected 
through the a b i l i t y  of the calmodulin antagonist drugs to ra ise 
myoplasmic Ca concentrations in normal skeletal muscle and thus 
mimic the symptoms of MH. Many inves tiga to rs , however, considered 
th e ir  NMS patients to have undergone a central e ffe c t o f the 
calmodulin antagonist drugs invo lv ing such mechanisms as dopamine 
receptor blockade (Henderson and Wooten, 1981), dopamine depletion 
(Burke, Fahn, Mayeux, Weinberg, Louis and W illner, 1981) and a 
combination of in h ib i t io n  of norepinephrine and dopamine reuptake 
together with blockade of post-synaptic dopamine receptors (Annsseau, 
D ir icq , Grisar and Collard, 1980). The phenothiazine drugs are also 
extensively used as premedication fo r  surgical procedures involv ing
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halothane anaesthesia (and other volatile inhalational anaesthetic 
triggers of MH) and succinylcholine. No consistent adverse effects 
of phenothiazine premedication on anaesthesia have been reported, 
although isolated cases of hypotension and tachycardia during 
anaesthesia have been considered to be due to this premedication 
(Dripps, Vandam, Pierce, Oech and Lurie, 1955; Gold, 1974). A 
possible role of the phenothiazine drugs (in the form of cough 
mixture) has also been considered in the Sudden Infant Death Syndrome 
(SIDS) (Kahn and Blum, 1979). This observation is of interest in the 
light of the recently described link between MH and the parents of 
some children who had died from SIDS (Denborough, Galloway and 
Hopkinson, 1982).
The observation that dantrolene sodium partially reversed 
contractures induced by calmodulin antagonist drugs i_n vi tro 
suggested that these drugs were acting, in part, on the E-C coupling 
mechanism to exert their effects on the contractile characteristics 
of both control and MHS porcine skeletal muscle. This proposal is 
consistent with the observations that dantrolene sodium had no effect 
on the Ca transport functions of isolated SR (White, Collins and 
Denborough, 1983), nor did i t  effect the changes produced in these 
functions by the calmodulin antagonist drugs. Also, E-C coupling is 
thought to be the si te of action of dantrolene sodium in skeletal 
muscle (Ellis and Bryant, 1972). The butyrophenone HPD differed from 
the phenothiazine calmodulin antagonist drugs in that, although at 
least as potent as these drugs in inducing changes in the in vitro 
contractile characteristics of control and MHS muscle, HPD-induced 
contractures were reversed to a much greater extent by dantrolene 
sodium (approximately 80%). Trifluoperazine-induced contractures
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(representative of the other phenothiazine drugs) were reversed
approximately 20% by dantrolene sodium. These observations suggested
that HPD induced i ts  in vitro contractile effects mainly through an
effect on E-C coupling. This was consistent with the observed
2+effects of HPD on isolated SR Ca transport functions, where very 
high concentrations of HPD were required to induce substantial 
effects. Another possible site of action of calmodulin antagonist 
drugs in control and MHS skeletal muscle was troponin C. This 
Ca -binding protein shows extensive sequence homology with 
calmodulin (Dedman, Jackson, Schreiber and Means, 1978) and has been 
shown to bind TFP (Levin and Weiss, 1978). This TFP binding to 
troponin C has been shown to involve Ca -binding site III on the
troponin C molecule (Klee, Crouch and Richman, 1980). Reid, Gariepy
2+and Hodges (1983) have shown that a synthetic, Ca -binding peptide 
analogue of si te  III of rabbit skeletal muscle troponin C bound a 
number of calmodulin antagonist drugs in a phenothiazine selective 
manner. These authors showed that the butyrophenone HPD had no 
effect on the circular dichroism spectrum or calcium sensitivity of 
this apopeptide. Thus, HPD may also differ from TFP in that i t  did 
not show appreciable binding to troponin C. These observations 
suggest that i t  would be interesting to further examine the effects 
of HPD on control and MHS muscle. The effects of HPD on E-C coupling 
might be substantiated, using the in vitro muscle strip preparation, 
by treatments which preferentially effected E-C coupling such as 
glycerol or deuterium oxide treatment prior to the addition of HPD 
(Okumura, Crocker and Denborough, 1980). I t  might also be
interesting to examine the feasability of constructing a HPD or 
dantrolene sodium affinity column. The passage, and subsequent
elution, of partially solubilized protein mixtures obtained from
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isolated light, intermediate and heavy SR fractions through such an 
affinity column might provide some insight into the mechanism of E-C 
coupling and the location of the dantrolene sodium binding site.
In both control and MHS porcine skeletal muscle calmodulin antagonist
94-drugs caused a disturbance of Ca ' regulation which led to a rise in 
2+ 2+the myoplasmic Ca concentration. When Ca regulation of control 
muscle was disturbed by calmodulin antagonist drugs, the muscle was 
observed to react to halothane, caffeine and succinylcholine with a 
MH-like i_n vitro hypercontractility. These observations supported
the hypothesis that the abnormality present in MHS muscle involved a
2 -*- 2+  disturbance of Ca ' regulation. The si te of this abnormality of Ca
2+regulation did not appear to involve the SR Ca transport functions 
since these functions did not differ between control and MHS isolated 
SR preparations. Among the calmodulin antagonist drugs studied in 
the present investigation, the hypercontractility of HPD-treated 
control muscle most closely resembled the hypercontractility of MHS 
muscle due to i t s  degree of reversal by dantrolene sodium. From the 
considerations discussed above i t  appeared that the HPD-induced 
hypercontractility of control muscle was caused mainly by an effect 
on the E-C coupling mechanism. Thus, the similarities between MHS 
muscle and HPD-treated control muscle implicated the E-C coupling 
mechanism as the site of the basic abnormality in porcine MH.
2+The present investigation into the role of the Ca regulatory
protein calmodulin in porcine MH has led to the following major 
conclusions:
- calmodulin was not abnormal in porcine MHS tissue
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- the calmodulin antagonist drugs used in the present investigation 
were neither specific nor selective for calmodulin when used in the 
pharmacological muscle str ip  preparation or the isolated SR membrane 
preparation
- the calmodulin antagonist drugs used in neuroleptic therapy 
(especially the phenothiazine and butyrophenone groups) may 
precipitate a MH episode in MHS individuals
- the si te of the basic abnormality in porcine MHS skeletal muscle 
appears to involve the E-C coupling mechanism.
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